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Abstract 
Avidin (Avd) is a protein first discovered in chicken egg white, and later in 
other birds, reptiles, amphibians and lancelet. Apart from these eukaryotic 
species, Avd is also identified in few fungal and in many bacterial species, 
the most well-known being streptavidin from Streptomyces avidinii. Avds 
are highly stable, homotetrameric – and in some cases dimeric – proteins, 
known for their extremely tight binding affinity to biotin; Kd~10-15 M for 
chicken Avd is the highest affinity observed for noncovalent ligand binding 
to a macromolecule. Due to the high affinity of Avds for biotin, the Avd-
biotin binding system has been utilized in numerous life sciences 
applications in the field of biotechnology, medical diagnostics and 
nanotechnology. 
Our collaborators have earlier developed circularly permuted, engineered 
Avd forms, dual-chain (dc) and single-chain (sc) Avds, which contain two 
and four, respectively, Avd subunits incorporated into one polypeptide 
chain. Each “domain” in dc and sc Avd thus corresponds to a monomer in 
wt Avd and have fully functional, high affinity biotin-binding site, which 
can be independently modified. The aim of this thesis was to structurally 
characterize novel Avd proteins, both natural and engineered forms, which 
bind non-biotin ligands, e.g. peptide ligands, steroids, and other small 
molecules. This provides the opportunity to create engineered dc or sc 
Avds, containing two or four distinct Avd domains having varied ligand-
binding affinities for biotin, or non-biotin ligands. This thesis focuses on 
the structure determination of several Avds that recognize ligands different 
from biotin, which could be incorporated into engineered dc and sc Avds 
with a mixture of ligand preferences. 
A number of artificial chicken Avd-based proteins, collectively called 
‘antidins’, were designed through random and specific mutations and 
selected to bind ligands other than biotin. An engineered steroid-binding 
antidin, binding progesterone with micromolar affinity, was selected for 
crystallization trials. We solved the crystal structures of the steroid-binding 
antidin, sbAvd-2 (I117Y) without [Protein Data Bank code (PDB):4U46] 
and with [PDB:5LUR] progesterone bound to each monomer of the 
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tetramer. We also modelled several high-affinity progesterone-binding 
antidins possessing nanomolar affinity for the progesterone ligand, and 
performed computational docking experiments on them to assess their 
complexes with progesterone and biotin. This enabled us to evaluate 
possible interactions of antidins with these small molecules, even without 
their X-ray structures. 
The natural tetrameric Avd, bradavidin from Bradyrhizobium 
diazoefficiens, a nitrogen-fixing bacterium present in the root nodules of 
soybean, provides novel opportunities for biotechnological uses of Avds 
because the wild-type (wt) bradavidin has a unique intrinsic C-terminal 
peptide ligand known as ‘Brad-tag’ bound to the binding site of the 
neighboring subunit. We have solved the X-ray structure of core-
bradavidin – an engineered form of wt bradavidin, where the C-terminal 
residues Gly114-Lys138 have been truncated, including the Brad-tag 
residues Gly129-Lys138 – in complex with biotin [PDB:4BBO]. 
Comparison of the wt bradavidin—Brad-tag and core-bradavidin—biotin 
binding mode elucidated the conformational changes required in the 
bradavidin binding site to accommodate the two different ligands (Brad-
tag vs. biotin). To better understand the mechanism and usefulness of Brad-
tag as an intrinsic ligand, we also modelled the structure of two proteins 
containing the Brad-tag sequence and which likely binds it: rhodavidin 
from Rhodopseudomonas palustris, and bradavidin A2 from 
Bradyrhizobium sp. Ai1a-2. 
The Avds detailed in this thesis include natural Avds binding intrinsic 
peptide ligands and artificial Avds, created through engineering or random 
mutagenesis, binding steroids or other small molecules. This study 
provides opportunities to design Avd-based scaffolds with tailor-made 
affinities for novel non-biotin ligands. These “domains” can be envisioned 
to be utilized as monomers per se in dimeric or tetrameric Avds, or as 
domains integrated into dc or sc Avds, designed for various 
bio(nano)technological applications in which simultaneous recognition 
and/or crosslinking of multiple molecular entities is advantageous. 
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Abstract in Swedish 
Avidin (Avd) är ett protein som först upptäcktes i kycklingäggvita och 
senare också i andra fåglar, reptiler, amfibier och lansettfiskar. Bortsett från 
dessa eukaryota arter finns Avd också i några svampar och i många 
bakteriearter. Det Avd som är bäst känt är streptavidin från Streptomyces 
avidinii. Avds är mycket stabila homotetramerer eller i vissa fall dimerer 
och är kända för sin extremt höga bindningsaffinitet för biotin, vilken för 
Avd från kyckling är Kd∼10-15 M och därmed den högsta affiniteten som 
observerats för icke-kovalent ligandbindning till en makromolekyl. På 
grund av Avds höga affinitet för biotin har Avd-biotinbindningssystemet 
använts i många biovetenskapliga tillämpningar inom bioteknik, 
medicinsk diagnostik och nanoteknik. 
Våra medarbetare har tidigare konstruerat cirkulärt permuterade Avd-
former med dubbla kedjor (dc, eng. dual-chain) och enkla kedjor (sc, eng. 
single-chain), som innehåller två respektive fyra Avd underenheter 
införlivade i en polypeptidkedja. Varje "domän" i dc och sc Avd motsvarar 
sålunda en monomer i vildtyps (wt, eng. wild type) Avd och har ett fullt 
fungerande biotinbindande ställe med hög affinitet som kan modifieras 
oberoende av den övriga molekylen. Syftet med denna avhandling var att 
strukturellt karakterisera nya naturliga och manipulerade former av Avd 
proteiner som binder andra ligander än biotin, t.ex. peptidligander, 
steroider och andra småmolekyler. Detta ger möjlighet att skapa 
manipulerade dc eller sc Avds som innehåller två eller fyra distinkta Avd 
domäner med varierande bindningsaffinitet för biotin eller andra ligander. 
Denna avhandling fokuserar på strukturbestämning av flera Avds som 
känner igen ligander som skiljer sig från biotin och som kan införlivas i 
konstruerade dc och sc Avds för att uppnå en blandning av 
ligandspecificiteter. 
Ett antal artificiella proteiner baserade på Avd från kyckling utformades 
genom slumpmässiga och specifika mutationer och de utvalda proteinerna 
binder andra ligander än biotin. Dessa proteiner kallas kollektivt 
"antidiner". Ett konstruerat steroidbindande antidin som binder 
progesteron med mikromolär affinitet valdes för kristalliseringsförsök. Vi 
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löste kristallstrukturerna för det steroidbindande antidinet sbAvd-2 
(I117Y) utan [Protein Data Bank Code (PDB): 4U46] och med [PDB: 
5LUR] progesteron bundet till varje monomer i tetrameren. Vi 
modellerade också strukturen hos flera progesteronbindande antidiner 
som har hög nanomolär affinitet för progesteron och utförde datorbaserade 
dockningsexperiment för att studera deras samverkan med progesteron 
och biotin. Därmed kunde vi utvärdera möjliga samverkningar mellan 
antidiner och dessa småmolekyler även utan tillgängliga strukturer. 
Bradyrhizobium diazoefficiens är en kvävefixeringsbakterie i sojabönornas 
rotknutar och dess naturliga tetrameriska bradaividin ger nya möjligheter 
till biotekniska användningar av Avds, eftersom det har en unik inre C-
terminal peptidligand känd som "Brad-tag" och som binder till 
bindningsstället hos den närliggande underenheten. Vi har löst 
röntgenstrukturen hos komplexet mellan biotin och kärnbradavidin [PDB: 
4BBO] som är en konstruerad form av wt bradavidin där de C-terminala 
aminosyrorna Gly114-Lys138 har tagits bort. Denna del omfattar också 
aminosyrorna Gly129-Lys138 som utgör Brad-tag. Jämförelse av hur Brad-
tag är bunden till wt bradavidin och biotin till kärnbradavidin belyser de 
konformationsändringar som krävs i bindningsstället hos bradavidin för 
att de två olika liganderna ska kunna binda. För att bättre förstå 
mekanismen och användbarheten av denna inre Brad-tag modellerade vi 
också strukturen hos två proteiner som innehåller aminosyrasekvensen för 
Brad-tag och som därmed sannolikt binder den. Dessa proteiner är 
rhodavidin från Rhodopseudomonas palustris och bradavidin A2 från 
Bradyrhizobium sp. Ai1a-2. 
De Avds som beskrivs i denna avhandling omfattar naturliga Avds som 
binder inre peptider som ligander och artificiellt konstruerade Avds eller 
Avds som skapats genom slumpmässig mutagenes och som binder 
steroider eller andra småmolekyler. Denna studie gör det möjligt att 
utforma Avd-baserade proteiner med en stomme som har skräddarsydd 
affinitet för nya ligander som inte är biotin. Dessa "domäner" kan antas 
bilda dimerer eller tetramerer eller även fungera som domäner integrerade 
i dc eller sc Avds som har utformats för olika biologiska eller nanotekniska 
användningsområden där samtidig igenkänning och/eller tvärbindning av 
flera molekylenheter är fördelaktigt. 
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1. Introduction 
Avidins (Avds) belong to the calycin superfamily. Other members of the 
calycin protein superfamily include e.g. lipocalins, fatty acid binding 
proteins, metalloprotease inhibitors and triabin (Flower et al., 2000). 
Chicken egg-white avidin (Avd) (Eakin et al., 1941; György and Rose, 
1941), and the homologous protein streptavidin from the bacterium 
Streptomyces avidinii (Chaiet and Wolf, 1964; Tausig and Wolf, 1964) are 
homotetrameric proteins that bind up to four molecules of vitamin B7 or 
vitamin H but commonly known as biotin (Btn). Both chicken Avd and 
streptavidin bind Btn with a high affinity, (Kd~10-15 M for chicken Avd) 
(Green, 1975). This exceptional affinity for Btn has made the Avd-Btn 
complex a key tool in various life science applications e.g. immunological 
assays, hybridization assays, affinity chromatography, and has thus given 
rise to chicken Avd-Btn and streptavidin-Btn based technologies (Barnard 
et al., 1986; Bayer and Wilchek, 1990; Diamandis and Christopoulos, 1991; 
Wilchek and Bayer, 1990), referred jointly as strept(avidin)-Btn 
technology. 
The strept(avidin)-Btn technology was further enhanced by the discovery 
of other natural avidins (Avds): eukaryotic (Määttä et al., 2009; Taskinen et 
al., 2013) and prokaryotic Avds (Avraham et al., 2015; Meir et al., 2009, 
2012; Sardo et al., 2011) providing alternative protein scaffolds, more 
generally referred herein as Avd-Btn technology. A few natural bacterial 
Avds have a C-terminal extension acting as intrinsic ligand (Avraham et 
al., 2015; Leppiniemi et al., 2012; LeTrong et al., 2006; Meir and Livnah, 
2010). These peptide ligands have the potential to be used as commercial 
tags e.g. Avi-tag (Meyer et al., 2006). Protein engineering through site-
directed mutagenesis has been used to study the Btn-binding affinity of 
Avds (Chilkoti et al., 1995a, 1995b; Dixon and Kollman, 1999; Freitag et al., 
1999; González et al., 1997, 1999; Hemminki, 1998; Laitinen et al., 1999, 
2001, 2003; LeTrong et al., 2003; Marttila et al., 1998, 2000; Morag et al., 
1996; Murakami et al., 2000; Nordlund et al., 2003; Pazy et al., 2001, 2003; 
Qureshi et al., 2001; Reznik et al., 1996, 1998; Sano and Cantor, 1995; Sano 
et al., 1995). Genetically engineered Avds were created to alter stability, 
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physicochemical and immunological properties, as well to change the 
ligand-binding affinity of selected monomer/s to either bind Btn with a 
lower affinity or bind ligands other than Btn e.g. peptide-tags, steroids; 
while maintaining the tight binding affinity of other monomers intact 
(Hytönen et al., 2005a, 2005b; Laitinen et al., 2006; Nordlund et al., 2004, 
2005a; Riihimäki, 2011).  
In this study, we solved the X-ray structure of core-bradavidin in complex 
with Btn, an artificially truncated form of wild-type (wt) bradavidin with 
an intrinsic C-terminal ligand ‘Brad-tag’ (Leppiniemi et al., 2012). We also 
solved the crystal structure of a steroid-binding Avd, sbAvd-2 (I117Y) in 
both the unliganded and progesterone-bound form. In addition, we built 
homology models of several artificial chicken Avd-based proteins – 
antidins – and performed computational docking studies with 
progesterone and Btn. All of these novel antidins provide the possibility to 
create engineered sc and dc Avds with up to four or two, respectively, Avd 
domains having ligand-binding affinities for non-Btn ligands. The Avds 
described in this study have potential for use in various applications in the 
field of bio(nano)technology and diagnostics. Furthermore, this study 
helps us to better understand the fine architecture of Avds and how the Avd 
scaffold could be further engineered towards improved binding preferences 
for non-Btn ligands of interest. 
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2. Review of literature 
2.1 Chicken avidin 
2.1.1 History of chicken avidin 
The high affinity between chicken Avd and Btn was responsible for the 
early discovery of this glycoprotein when Eakin et. al. discovered that 
animals maintained on a strict egg white diet were deficient in Btn despite 
having the vitamin in their diet (Eakin et al., 1941; György and Rose, 1941). 
Apart from the use of Btn as a vitamin and nutrient (Sebrell and Harris, 
1954), Btn is also involved in post-transcriptional events in Avd induction 
by progesterone (Tuohimaa et al., 1976). Chicken Avd was long regarded 
as a chicken oviduct and progesterone-specific protein (Kohler et al., 1968; 
O’Malley, 1967) but it was later seen that Avd can also be induced in a 
progesterone-independent environment in several other chicken tissues; 
for e.g., during an inflammatory reaction caused by tissue trauma, pinching 
or heat injury, or by infection via microorganisms (Elo, 1980; Elo and 
Korpela, 1984; Elo et al., 1975, 1981, 1979a, 1979b; Heinonen and 
Tuohimaa, 1976; Heinonen et al., 1978; Korpela et al., 1983; Kulomaa, 1982; 
Niemelä et al., 1986; Nordback et al., 1981, 1982).  
Once the role of Btn as a cofactor of enzymes was discovered (Wakil et al., 
1958), the strong binding of Avd with Btn was utilized as a tool for studying 
the mode of action of Btn in carboxylation and transcarboxylation 
reactions (Finn et al., 1979; Hofmann et al., 1982). In fact, most of the 
research on Avds in the 1970’s concentrated on the variety of application 
achieved by the Avd-Btn interaction, which is now known as Avd-Btn 
technology. These technologies are reviewed e.g. by (Airenne et al., 1999; 
Laitinen et al., 2007; Wilchek and Bayer, 1989, 1990); and include uses as 
bioaffinity sensors, for affinity targeting, pretargeting, drug delivery, and 
flow cytometry.  
2.1.2 Distribution and function of chicken avidin 
Chicken Avd was first discovered in hen egg-white (Eakin et al., 1941), 
followed by identification of Avds in the egg-white of turkey, duck, goose, 
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and in the egg jelly of frog (Hertz and Sebrell, 1942). Since then, the 
distribution of Avd in the egg-white of oviparous species has been observed 
and studied (Korpela et al., 1981). Due to the occurrence of Avd in the 
genital tracts and eggs of birds, and its regulation by steroids, an important 
role for Avd had been suggested in the physiology of avian reproduction 
(Hertz, 1946; Hertz and Sebrell, 1942; Korpela et al., 1981), but the exact 
role(s) of Avd in reproduction is still unresolved.  
Chicken Avd could act to store the essential vitamin for use by the growing 
embryo. Although, the highest non-covalent binding observed in nature 
argues against this since the binding is essentially irreversible. The chicken 
egg white contains other Btn-binding Avd-like proteins with different 
affinities towards Btn, which could provide functions such as Btn storage 
and release, and other yet unknown functions (see section 2.4). 
An anti-microbial function of high-affinity chicken Avd seems most likely, 
as inhibition of several microorganisms was demonstrated by Eakin et. al. 
and Green (Eakin et al., 1941; Green, 1975). The antimicrobial function of 
the bacterium Streptomyces sp. (known for producing a wide range of 
antibiotics) containing streptavidin, and the similarity of streptavidin and 
chicken Avd is already known (Green, 1975). The eggs of hens have 
multiple proteins acting to protect the egg from contamination, including 
lysozyme, conalbumin and riboflavin-binding protein, and it is not 
unreasonable to suggest that the extreme Btn-binding affinity of Avd plays 
a protective role, too. Chicken Avd could function to mop-up the free Btn 
in the egg white and hence help prevent infection of the egg by 
microorganisms, which the egg will encounter in the cloaca – where 
excretion also takes place and thus is highly contaminated – and in the 
environment after laying.  
Apart from the excretory/genital tracts and eggs, chicken Avd was also 
found in the injured tissues of chicks (Eakin et al., 1940; György, 1939; 
György et al., 1941). Avd production was caused by the local muscular 
injury and was restricted to the inflammation site. This suggested a possible 
function of Avd during tissue inflammation of chickens (Elo, 1979; Elo and 
Korpela, 1984; Elo et al., 1981). Both chicken Avd and streptavidin, 
collectively called as (strept)avidin, have also been suggested to have a role 
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in the regulation of cell proliferation (Zerega et al., 2001). Bjavidin 1 and 2 
from Branchiostoma japonicum have recently been shown to bind Btn but 
also recognize bacteria and enhance phagocytosis (Guo et al., 2017). 
2.1.3 Structure of chicken avidin 
Green and his coworkers studied the chicken Avd molecule through 
preliminary crystallographic analysis of Avd crystals (Green and Joynson, 
1970) as well as electron-microscopic examination (Green et al., 1971) and 
concluded that chicken Avd tertiary structure has four subunits arranged 
in a two-fold symmetry; later proved by X-ray crystal structures (Livnah et 
al., 1993a; Pugliese et al., 1993, 1994). 
Chicken Avd is a homotetrameric protein (Green and Toms, 1970) with 
each monomer made of eight antiparallel β-strands. The ligand-binding 
site is located on one end of each monomer, lined by polar and aromatic 
residues (Livnah et al., 1993a); each subunit has two cysteine residues 
forming a disulphide bridge that contributes to Avd stability (Green, 1975). 
Chicken Avd is about 62 KDa in size. Chicken Avd is proteolytically cleaved 
releasing the N-terminal signal peptide of 24 amino acids and producing 
the mature protein of a 128 amino acids; chicken Avd is glycosylated at 
Asn17 (Gope et al., 1987; Green, 1975). The protein has an isoelectric point 
of pH 10.5. The dissociation constant, Kd, of chicken Avd from Btn, at a pH 
nefar 7, is ~10-15 M. The strong avidity for Btn is the most characteristic 
property of the Avd protein. Avd is also highly thermostable, with the Tm 
increasing from ~85°C in the absence of Btn to about 118°C when Btn is 
bound (Donovan and Ross, 1973; González et al., 1999; Nordlund et al., 
2003). 
The tetramers in Avd are arranged in a 1-4, 2-3 fashion (subunit numbering 
from (Livnah et al., 1993a)), as a dimer of dimers (Figure 1). Being a 
tetrameric protein, the monomers are held together by three forms of 
monomer-monomer interactions; subunit 1 - subunit 4 (IF1,4), subunit 1 - 
subunit 3 (IF1,3) and subunit 1 - subunit 2 (IF1,2) interface is stabilized by 
hydrogen bonds (H-bonds), hydrophobic bonds and van der Waals 
interactions (Livnah et al., 1993a), which contribute to the rigidity of the 
quaternary structure and directly to 
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Figure 1: Cartoon model of the chicken Avd [PDB: 1AVD] (Pugliese et al., 1993). 
(a) tetrameric structure of chicken Avd (top) and a schematic representation 
(bottom) showing the arrangement of the subunits 1-4. (b)  side view of the chicken 
Avd tetramer (left) and a top view of the tetramer (right). The monomers are 
arranged in a “1-4 and 2-3 scheme” similar to as described in Livnah et.al. 1993a. 
The four subunits are colored green (subunit 1), magenta (subunit 2), cyan (subunit 
3) and yellow (subunit 4). The carbon atoms of the Btn ligand in each subunit are 
colored according to their subunit and are shown as spheres. Nitrogen atoms in Btn 
are colored blue, oxygen atoms red and sulphur atoms yellow. The figure scheme is 
adapted from Meir et al. (2009) Journal of molecular biology, 379–390. 
 
the Btn-binding mode of Avds (see below) (Livnah et al., 1993a). However, 
even slight changes in key amino acid residues at the interface are able to 
disrupt the tetrameric structure (Laitinen et al., 1999, 2001, 2003). 
The largest contact surface area between the Avd subunits is formed by the 
IF1,4 interface (similar to IF2,3) with a surface area of 1951 Å2 per 
monomer. IF1,4 forms a structural pair supported by a number of H-bonds 
and other weak interactions between them. The IF1,2 interface has a surface 
(a) 
90º 
(b) 
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area of 729 Å2. IF1,3 has an area of 120 Å2 making it the weakest monomer-
monomer interface. The major interactions at this interface are polar and 
van der Waals interactions among hydrophobic residues Met96, Val115 
and Ile117. 
In the Btn-free apo form, water molecules partially occupy the chicken Avd 
binding site but are easily displaced by Btn. When Btn binds to Avd, the 
L3,4 loop (loop region connecting β-strand 3 and 4) adopts a closed 
conformation, acting as a lid to tightly seal Btn inside the binding pocket 
(Pugliese et al., 1994) Trp110 in the L7,8 loop from the neighboring subunit 
holds special importance during Btn binding because it seals off the binding 
site from one end, and forms a hydrophobic pocket with Phe79 and Trp97 
from the original subunit, holding Btn in place (Livnah et al., 1993a). 
The chicken Avd-Btn complex requires extreme environmental conditions 
for denaturation: it is stable over a wide range of pH and temperature, and 
is resistant to most proteases (Donovan and Ross, 1973; Green, 1963a). 
Chicken Avd, either in its apo form or bound with Btn, has use in various 
applications (See section 2.6), e.g. affinity chromatography, diagnostics, 
immunoassays and drug delivery (Wilchek and Bayer, 1989).  
2.2 Streptavidin 
Streptavidin was first isolated in culture media from several species of 
Streptomyces (Chaiet and Wolf, 1964; Tausig and Wolf, 1964). The 
chemical nature, structure and Btn-binding properties of streptavidin had 
been observed to be similar to chicken Avd (Chaiet and Wolf, 1964; Tausig 
and Wolf, 1964), with the Kd~10-14 M for the streptavidin-Btn complex 
(Green, 1990). The thermostablility of streptavidin with attached Btn is 
~112°C and sans Btn is ~84°C (González et al., 1999). 
Native full-length streptavidin contains 159 amino acids and is processed 
at the N- and C-termini to give what is called core-streptavidin, having 
typically 127 amino acids (Pähler et al., 1987). The truncated core-
streptavidin has higher solubility in water and has been shown to have 
better Btn-binding properties than wild-type (wt) streptavidin (Green, 
1990). Core-streptavidin also lacks cysteine and methionine residues, but 
has six tryptophan residues per subunit (Chaiet and Wolf, 1964). The lack 
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of cysteine residues means that, unlike chicken Avd, streptavidin has no 
disulphide bridge (Livnah et al., 1993a).  
Soon after solving the crystal structure of streptavidin (Weber et al., 1989), 
it was suggested that streptavidin is structurally similar to lipocalins, 
another member of the calycin superfamily (Flower, 1993) – lipocalins also 
consists of eight anti-parallel β sheets, with a ligand-binding site in the 
middle of the β-barrel structure. In comparison to streptavidin, the loop 
architecture of lipocalins is different, the N-terminal sequence seals the β-
barrel and a characteristic α-helix after the β8 strand is present on the C-
terminal end (Flower, 1993). 
Within the Avd family of proteins, X-ray analyses have shown that the even 
though chicken Avd and streptavidin are only about 35% identical in amino 
acid sequence, the folds of both Avds are conserved, and so are most of the 
residues important for binding Btn (Bayer and Wilchek, 1990). The 
importance of tryptophan in Btn binding was stressed by Green (Green, 
1975), and confirmed by site-directed mutagenesis on streptavidin 
(Chilkoti et al., 1995a; Laitinen et al., 1999; Sano and Cantor, 1995; Wu and 
Wong, 2005). Other key residues were similarly shown to be important for 
Btn binding, including tyrosine (Tyr43 in streptavidin) (Gitlin et al., 1989, 
1990; Hiller et al., 1991) and lysine (Lys45, Lys94, Lys111 in streptavidin) 
(Gitlin et al., 1987). Streptavidin also differs in sequence at the binding site 
with respect to chicken Avd: Phe79 in chicken Avd is replaced by Trp92 in 
streptavidin while Phe72 in chicken Avd appears not to have a structural 
counterpart in streptavidin. In addition, the L3,4 loop in streptavidin is 
shorter by four residues in comparison with chicken Avd (Stenkamp et al., 
1997). 
The major subunit interfaces in streptavidin are similar to those in chicken 
Avd. However, in the case of IF1,3, Gln97 and His127 in streptavidin 
replace Met96 and Ile117 in chicken Avd; the side chain of His127 from 
two subunits participate in π-π stacking with each other at the interface, 
contributing to streptavidin’s stability (Livnah et al., 1993a).  
Core-streptavidin, wt streptavidin and a Btn-conjugated form are all used 
in various applications such as for immobilizing agents, flow cytometry, 
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histochemistry, and bioaffinity sensors ((Wilchek and Bayer, 1989) and 
references therein). 
2.3 (Strept)avidin-biotin binding 
Chicken Avd has four binding sites for Btn, one in each subunit (Chignell 
et al., 1975; Green, 1966). In addition to hydrophobic interactions by 
tryptophan and phenylalanine residues (Chilkoti et al., 1995a), the ureido 
ring of Btn in chicken Avd is involved in five crucial hydrogen bonding 
interactions: with Asn12, Ser16, Tyr33, Thr35 and Asn118. In addition, the 
sulfur atom of Btn interacts with Thr77, and the two carboxylate oxygen 
atoms of the valeric acid tail of Btn can H-bond with Thr38, Ala39, Thr40, 
Ser73, Ser75 (Livnah et al., 1993a; Pugliese et al., 1993) making a total of up 
to eleven hydrogen bonds for the Avd-Btn complex. 
In streptavidin, a similar network of H-bonds is observed. The ureido ring 
forms three H-bonds: with Asn23, Ser27 and Tyr43. The ring nitrogen 
atoms N1ʹ and N3ʹ respectively H-bond with Asp128 and Ser45. The sulfur 
atom of Btn forms an H-bond with Thr90, and the carboxylate oxygen 
atoms of the valeric acid tail form two H-bonds: one with the main-chain 
nitrogen atom of Asn49 and another with the side-chain hydroxyl group of 
Ser88 (Livnah et al., 1993a; Weber et al., 1989) making a total of eight H-
bonds for the streptavidin-Btn complex. The existence of fewer H-bonds, 
together with a lack of one hydrophobic interaction (equivalent to Phe72 
in chicken Avd), leads to 100-fold lower affinity for Btn by streptavidin 
than is seen for chicken Avd (Figure 2). 
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Figure 2: Hydrogen bonding network in (a) chicken Avd [PDB: 1AVD] (Pugliese 
et al., 1993) and (b) streptavidin [PDB: 1STP] (Livnah et al., 1993a; Weber et 
al., 1989). (a) Side chains of residues forming H-bonds with Btn (green carbon 
atoms) in chicken Avd [PDB: 1AVD] (orange carbon atoms) and (b) with Btn 
(purple carbon atoms) in streptavidin [PDB:1STP] (cyan carbon atoms) are shown 
as thick sticks. Nitrogen atoms are colored blue, oxygen atoms red and sulfur yellow. 
The H-bonds are drawn as grey dashed lines and the distances are in Ångströms. 
  
(a) 
(b) 
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2.4 Other natural avidins and biotin-binding proteins 
Owing to their early discovery, the best-studied Avds are chicken (Gallus 
gallus) Avd and the bacterial streptavidin from Streptomyces avidinii. Apart 
from these two well-studied Avds, there are many other Avds from 
different organisms whose sequences have been reported and some have 
been expressed and characterized in detail, including structural studies.  
Avds from several other eukaryotic species (see (Tiwari, 2015)), such as 
Ostrich (Struthio camelus australis) (Zhang et al., 2014), American alligator 
(Alligator mississippiensis) (St John et al., 2012); fungal Avds like 
lentiavidins from Lentinula edodes (Takakura et al., 2016); bacterial Avds 
such as burkavidin from Burkholderia pseudomallei (Sardo et al., 2011), as 
well as Mycobacterium thermoresistible and the recently discovered 
BjAvidin 1 and 2 from the invertebrate lancelet (amphioxus;Branchiostoma 
japonicum) (Guo et al., 2017) have been described. 
Examples of different Avds with solved three-dimensional (3D) structures 
include: the eukaryotic Avds zebavidin [PDB: (4BJ8)] from zebrafish 
(Danio rerio) (Taskinen et al., 2013), xenavidin [PDB: 2UYW] from frogs 
(Xenopus tropicalis)(Määttä et al., 2009); the fungal Avds tamavidin 1 and 
2 [PDB: 2ZSC] from mushrooms (Pleurotus cornocopiae) (Takakura et al., 
2009); and the bacterial Avds bradavidin [PDB: 2Y32] (Leppiniemi et al., 
2012) and bradavidin II [PDB: 4GGR] (Leppiniemi et al., 2013) from 
Bradyrhizobium japonicum (Delamuta et al., 2013; Helppolainen et al., 
2008; Nordlund et al., 2005b), dimeric rhizavidin from Rhizobium etli 
[PDB: 3EW1](Helppolainen et al., 2007; Meir et al., 2009), shwanavidin 
[PDB: 3SZJ] from the bacterium Shewanella denitrificans (Meir et al., 2012) 
and hoefavidin [PDB: 4Z6J] from Hoeflea phototropica (Avraham et al., 
2015) (Table 1).  
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Table 1: Examples of experimentally determined 3D Avd structures from the 
PDB 
Protein Organism Name PDB ID Oligomeric 
state 
Reference 
Chicken avidin  Gallus gallus 1AVD Tetrameric (Pugliese et al., 
1993)  
Streptavidin Streptomyces 
avidinii 
2BC3  
(Full-length) 
3RY1 (Core) 
Tetrameric 
 
Tetrameric 
(LeTrong et al., 
2006) 
 
(LeTrong et al., 
2011)  
Xenavidin Xenopus tropicalis 
(Western clawed 
frog) 
2UYW Tetrameric (Määttä et al., 2009)  
Zebavidin Danio rerio 
(zebrafish) 
4BJ8 Tetrameric (Taskinen et al., 
2013)  
Bradavidin Bradyrhizobium 
diazoefficiens 
2Y32  Tetrameric (Leppiniemi et al., 
2012)  
Tamavidin Pleurotus 
cornucopiae 
(Tamogitake 
mushroom) 
2ZSC Tetrameric (Takakura et al., 
2009)  
Bradavidin II Bradyrhizobium 
diazoefficiens 
4GGR Uncertain 
(highly 
oligomeric) 
(Leppiniemi et al., 
2013)  
Rhizavidin Rhizobium etli 3EW1 Dimeric (Meir et al., 2009)  
Shwanavidin Shwanella 
denitrificans 
3SZJ Dimeric (Meir et al., 2012)  
Hoefavidin Hoeflea 
phototrophica 
4Z6J Dimeric (Avraham et al., 
2015)  
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The essential Btn-binding residues are partly conserved in Avds, depending 
on the oligomeric state (tetrameric/dimeric) and species (eukaryotic/ 
prokaryotic). For example, through sequence alignment of identified Avd 
sequences, it was observed that all tetrameric Avds have a tryptophan 
residue identical to Trp110 in chicken Avd. It is one of the most critical 
amino acids needed for Btn binding, as it seals the binding pocket from one 
side (Chilkoti et al., 1995a; Laitinen et al., 1999; Sano and Cantor, 1995), as 
well as ensuring the stability of the tetramer by contributing to IF1,3 
subunit interactions. 
In addition to chicken Avd, the chicken genome contains other Btn binding 
and Avd-like proteins, namely: biotin-binding proteins (BBPs) (Bush et al., 
1988; Meslar et al., 1978; White et al., 1976) and avidin-related proteins 
(AVRs) (Ahlroth et al., 2000; Hytӧnen, 2005; Keinänen et al., 1988, 1994; 
Wallén et al., 1995). Even though the overall tetrameric structure is 
conserved, BBPs and AVRs presumably differ in their functional roles in 
chicken. In general, BBPs and AVRs have lower affinity towards Btn in 
comparison to chicken Avd and even recognize ligands other than Btn; 
BBP-A, for example, D-biotin D-sulfoxide (BSO) (Hytӧnen et al., 2007). 
Their physiochemical properties, e.g. isoelectric point and thermal stability, 
also vary considerably from chicken Avd. Examples of a few natural Avds, 
BBPs, and AVR proteins are discussed in detail below. 
2.4.1 Biotin-binding proteins (BBPs) – Around the same time as chicken 
egg white Avd was discovered, the egg yolk was thought to contain another 
macromolecule forming a complex with Btn (György and Rose, 1941). 
However, identification of what turned out to be two biotin-binding 
proteins – BBP-I and BBP-II – was made many years later (Bush et al., 1988; 
Meslar et al., 1978; Subramanian and Adiga, 1995; White and Whitehead, 
1987; White et al., 1976). Due to their lower affinity for Btn in comparison 
to chicken Avds, BBPs were thought to serve as carrier proteins, which 
deliver Btn to the developing chick embryo, as they could release Btn as and 
when required (White and Whitehead, 1987). 
In comparison to BBP-II (Bush et al., 1988; Subramanian and Adiga, 1995; 
White and Whitehead, 1987), BBP-I had higher affinity for Btn (Kd~10-12 
M) as well as a thermal stability similar to chicken Avd (Meslar et al., 1978; 
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White et al., 1976). It is still not known with certainty whether the cDNAs 
encoding two other reported chicken Avds, BBP-A and BBP-B (Niskanen 
et al., 2005), correspond to BBP-I or BBP-II. 
The crystal structure of BBP-A is tetrameric [PDB: 2C1Q] (Hytӧnen et al., 
2007) (Figure 3a), but is less stable (Tm of 103.4°C in the presence of Btn) 
than chicken Avd. The reason for this may be the higher positive surface 
charge and 10% larger solvent accessible surface area, along with higher β-
barrel flexibility of BBP-A [PDB: 2C1Q] in comparison to chicken Avd-Btn 
complex [PDB: 2AVI]. The affinity of BBP-A towards Btn (Kd~10-13 M) is 
quite similar to that of streptavidin, and interestingly, BBP-A binds D-
biotin D-sulfoxide (BSO) tighter (Kdiss~1.3 x 10-4 s-1) than Btn (Kdiss~5.4 x 
10-4 s-1) (Hytӧnen et al., 2007). 
2.4.2 Avidin-related proteins (AVRs) – Avidin-related genes were first 
cloned by Keinänen in 1988 with the discovery of AVR1, AVR2 and AVR3 
(Keinänen et al., 1988). AVR4 and AVR5 were cloned in 1994 (Keinänen et al., 
1994), and AVR6 and AVR7 in 2000 (Ahlroth et al., 2000). The number of 
AVR genes varies among individual chicken cells, possibly because of frequent 
recombination inside the gene family (Ahlroth et al., 2001). 
The discovery of AVRs led to the possibility that the chicken genome may 
have more than one functional gene for Avd, but this does not appear to be 
the case. Out of the seventeen residues that interact with Btn in chicken 
Avd, between twelve and fourteen are conserved in AVR genes (Keinänen 
et al., 1994; Laitinen et al., 2002). Furthermore, in comparison to chicken 
Avd (Laitinen et al., 2002), the AVRs have distinctly different properties: 
Btn-binding affinities range from the Avd-like tight affinity of AVR4 (Kd 
~10-14 M) (Eisenberg-Domovich et al., 2005; Hytӧnen et al., 2004) to the 
affinity of AVR2 (Kd =5.2x10-8 M) (Laitinen et al., 2002). In addition, AVRs 
can be even more thermostable than chicken Avd (Tm ~85°C for the apo 
protein and ~118°C for the Btn-bound form), e.g. AVR4 (Tm ~106°C for 
apo protein and ~125°C for the Btn-bound form). The increased 
thermostability of AVR4 was suggested to be due to Tyr115 at the IF1,3 
interface and the shorter L4,5-loop (Hytӧnen et al., 2004) (Figure 3b). 
2.4.3 Rhizavidin – Rhizavidin was isolated from the nitrogen-fixing 
bacterium Rhizobium etli found in the root nodules of leguminous plants 
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(Helppolainen et al., 2007) and was the first natural dimeric Avd structure 
solved from the Avd family (Meir et al., 2009) [PDB: 3EW1]. The two 
monomers in rhizavidin form a structural pair similarly to the monomers 
forming the IF1,4 interface in chicken Avd (Meir et al., 2009) (Figure 3c). 
Even though rhizavidin is dimeric in solution, it formed a hexameric 
assembly (trimer of dimers) in the asymmetric unit of the crystal. In the 
hexameric assembly, the C-terminal end (residues 132-135) from one 
rhizavidin monomer binds to the Btn-binding site of the adjacent dimer in 
the hexamer and vice versa (Meir and Livnah, 2010). 
The L7,8 loop of rhizavidin, which is shorter in comparison to most other 
Avds, has a unique Gly-Gly-Ser-Gly sequence, resulting in a different loop 
conformation. Rhizavidin also has a disulphide bridge (a structural feature 
seen in the dimeric Avds shwanavidin (Meir et al., 2012) and hoefavidin 
(Avraham et al., 2015)), connecting the L3,4 and L5,6 loop, hence forming a 
different conformation of the L3,4 loop in comparison to chicken Avd. Unlike 
for tetrameric Avds, in dimeric rhizavidin there is no analogous tryptophan to 
Trp110 present in chicken Avd, hence the disulphide bridge is important in 
providing rigidity to the structure as well as to the ligand-binding site. 
The disulphide bridge in rhizavidin also aids in Btn-binding, but the affinity of 
rhizavidin for Btn is still weaker than for tetrameric Avds (Kd ~10-9 M) 
(Helppolainen, 2009). Livnah and coworkers have described the importance 
of the L3,4 loop conformations and how it affects the ligand binding of chicken 
Avd and streptavidin (Livnah et al., 1993a; Pazy et al., 2002). In rhizavidin, the 
difference in the L3,4 loop conformation together with the exposure of the 
binding site due to the absence of Trp110 can be a possible explanation for the 
weaker Btn-binding affinity of rhizavidin. The Tm of apo-rhizavidin is 75˚C, 
which is close to the Tm of apo-streptavidin, but the Tm of Btn-bound 
rhizavidin is only 100.5°C, significantly lower than Btn-bound streptavidin 
with Tm of 112°C (González et al., 1999; Helppolainen et al., 2007). 
2.4.4 Wild-type bradavidin – Bradavidin was identified in 
Bradyrhizobium diazoefficiens (Delamuta et al., 2013; Nordlund et al., 
2005b), a nitrogen-fixing bacteria present in the root nodules of soybean 
(Nordlund et al., 2005b). The crystal structure of this homotetrameric 
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protein was solved by Leppiniemi et al. in 2012 [PDB:2Y32] (Leppiniemi et 
al., 2012). 
The X-ray structure of wt bradavidin revealed that the C-terminal tail acts as 
an intrinsic intersubunit ligand bound to the Btn-binding pocket of an 
adjacent subunit, e.g. the binding pocket of subunit 1 is occupied by the C-
terminal end of subunit 3 and vice versa (Figure 3d). This bound peptide 
GSEKLSNTKK, was named the “Brad-tag” (Leppiniemi et al., 2012) and three 
residues – Glu131, Lys132 and Leu133 – occupy the site equivalent to where 
Btn binds in chicken Avd [PDB:1AVD]. The homotetrameric wt bradavidin 
has a disulphide bridge stabilizing the L3,4 – L5,6 loop, which is typical of the 
identified dimeric Avds (see section 2.4.3). To accommodate the Brad-tag, the 
ligand-binding pocket widens, the disulphide bridge conformation alters and 
the L3,4 loop stays in the ‘open’ conformation (Leppiniemi et al., 2012). In 
addition to wt bradavidin with 138 amino acid residues, an engineered C-
terminally truncated “core-bradavidin” with 118 residues – lacking residues 
Gly114-Lys138 – was also produced (Nordlund et al., 2005b). 
Bradavidin shares less than 30% sequence identity with chicken Avd and 
streptavidin, and is immunologically different, too. Wild-type bradavidin 
has an acidic pI of 6.3 and core-bradavidin has a pI of 4.1. The Btn-binding 
affinity of wt bradavidin is also weaker (Kd~10-7 M) than that of core-
bradavidin (Kd~10-9 M), indicating that the Brad-tag competes and 
interferes with Btn binding to wt bradavidin. The Tm of wt bradavidin sans 
Btn is 96°C, whereas in the presence of Btn the Tm increases to 101°C; this 
difference and magnitude of the Tm values are not as pronounced as for 
other tetrameric Avds. 
Bradavidin is the first Avd seen to have an intrinsic intersubunit ligand, 
naturally bound to the Btn-binding site. In contrast, wt streptavidin binds 
the C-terminal Strep-tag sequence within the Btn binding site of the same 
subunit (Figure 4), hence making it an intrasubunit ligand (LeTrong et al., 
2006). The Brad-tag is also found in rhodavidin from Rhodopseudomonas 
palustris (Larimer et al., 2004) and a few other Bradyrhizobium species. 
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Figure 3: Cartoon model of (a) tetrameric BBP-A [PDB:2C1Q], (b) tetrameric 
AVR4 [PDB: 1Y55], (c) dimeric rhizavidin [PDB:3EW2] and (d) subunit 1 and 
3 from tetrameric wt bradavidin [PDB:2Y32]. (a) Subunits 1-4 in BBP-A are 
colored as in Figure 1. Btn is shown in spheres (grey carbon atoms). (b) Subunits 1-
4 and Btn colored as in Figure 1. Additionally, Tyr115, known to increase 
thermostability of AVR4, is shown as sticks (black). (c) Subunit 1 (cyan) and subunit 
2 (green) are shown in the dimeric rhizavidin. Btn is shown as sticks (grey). (d) 
Subunits 1 (magenta) and 3 (green) are shown from wt bradavidin. Nitrogen atoms 
in all the panels are colored blue, oxygen atoms red and sulfur yellow. 
The potential of the Brad-tag for use in Avd-Btn technology was tested by 
creating Brad-tag–EGFP (enhanced green fluorescent protein) fusion 
proteins, with and without a poly-histidine tag. In short, agarose beads were 
(b) (a) 
(d) (c) 
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conjugated to core-bradavidin in order to purify Brad-tagged EGFP from 
other proteins in the cell lysate. The Brad-tag is specific for the bradavidin-
binding site and binds to core-bradavidin with micromolar affinity; the 
Brad-tag did not bind to chicken Avd, streptavidin or rhizavidin 
(Leppiniemi et al., 2012). 
 
 
Figure 4: Schematic representation of intrinsic peptide ligand binding in (a) 
streptavidin [PDB: 2BC3] and (b) wt bradavidin [PDB: 2Y32]. (a) Subunit 1 of 
streptavidin (green) is shown with the C-terminal acting as a intrasubunit ligand 
binding to the Btn-binding site. (b) In contrast, subunit 1 and 3 of wt bradavidin 
(blue) are shown where the C-terminal acts as a intersubunit ligand binding to the 
Btn-binding site of the neighboring subunit. The N and C terminals of both the Avds 
are shown in black. 
2.5 Ligands of avidin 
2.5.1 Biotin and its analogues 
The natural ligand of Avds is Btn. The importance of Btn for various 
biochemical and cellular processes was already noted quite early (György, 
1939), whereas the structure of Btn itself was determined much later 
(DeTitta et al., 1976; Trotter and Hamilton, 1966). Enzyme-bound Btn 
functions as a carrier of an activated carboxyl group in carboxylation, 
decarboxylation and transcarboxylation reactions (Chapman-Smith and 
Cronan Jr, 1999; McMahon, 2002; Wakil et al., 1958). Btn is also known to 
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regulate the expression of various genes, e.g. glucokinase (Chauhan and 
Dakshinamurti, 1991; Dakshinamurti and Litvak, 1970), Btn-dependent 
carboxylases and holocarboxylase synthetase (Rodríguez-Meléndez et al., 
2001; Solórzano-Vargas et al., 2002), Btn-transporters (Crisp et al., 2004; 
Manthey et al., 2002), cytokines (Manthey et al., 2002; Rodríguez-Meléndez 
et al., 2003; Zempleni et al., 2001) and oncogenes (Pacheco-Alvarez et al., 
2002). Deficiency of Btn in humans is known to cause a decline in 
carboxylase activity (Manthey et al., 2002) leading to hypoglycemia and 
ketosis due to a non-functional enzyme, pyruvate carboxylase (Bender, 
1999). The functions of other enzymes, such as acetyl-CoA carboxylase 
(Kopinski et al., 1989), propionyl-CoA carboxylase (Bender, 1999) and 
methylcrotonyl-CoA carboxylase (Mock and Stadler, 1997; Mock et al., 
1997), are also affected due to a lack of Btn. The specific mechanism of Avd-
Btn binding is described in section 2.3. 
2.5.1.1 Biotin derivatives – Even though Btn derivatives bind to the Avd 
ligand-binding site with a lower affinity than Btn, derivatives have played 
an important role in (strept)avidin-Btn technology. For example, Btn 
derivatives with alkyl and polyethylene glycol (PEG) chains coupled with 
DOTA (2,2′,2′′,2′′′-(1,4,7,10-tetraazacyclododecane-1,4,7,10-
tetrayl)tetraacetic acid) have been used to detect pancreatic islet of 
Langerhans coated with Avd in a liver transplantation model (Blom et al., 
2009). Photobiotin, another Btn derivative, can be linked to amino groups 
by photoactivation. This molecule can be further used to label DNA and 
RNA (Forster et al., 1985), and for covalent immobilization of various 
macromolecules at defined locations on nitrocellulose and polystyrene 
surfaces (Hengsakul and Cass, 1996). 
The binding of different derivatives to Avd suggests that the ureido ring of 
Btn is of great importance for tight binding ((Green, 1975) and references 
therein) – compounds that have modifications of the ureido ring bound 
less firmly to the chicken Avd-binding site than derivatives without 
modifications to the ring (Green, 1963b, 1966). A summary of these 
derivatives can be found in (Green, 1975). Overall, it seems that every atom 
in the Btn molecule contributes to the interaction with Avd, leading to the 
maximal affinity observed for noncovalent binding in nature. 
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2.5.2 Other ligands of avidin 
2.5.2.1 Azo compounds – Apart from Btn and its derivatives, some other 
small molecules such as azo derivatives (Repo et al., 2006), having little or 
no structural similarity to Btn, are also bound by Avds (Green, 1975). The 
binding affinities of these compounds are considerably lower in 
comparison to Btn, e.g. Kd~1 ×10–4 M for streptavidin (Green, 1990), and 
they are easily displaced in solution. For example, the displacement of an 
azo compound like 4-hydroxyazobenzene-2-carboxylic acid (HABA) by 
Btn has been used to quantitatively measure Btn-binding activity through 
spectrophotometric techniques developed by Green (Green, 1965). The 
affinity of chicken Avd (Kd~7.9 ×10–6 M for HABA (Määttä et al., 2008)) 
has been modified to improve the affinity for HABA. The N118 residue of 
Avd, which did not make a favorable interaction with HABA in the HABA-
Avd complex (Livnah et al., 1993b), was mutated to methionine leading to 
a Kd of 5.2 ×10–6 M; but the circular permutant cpAvd4→3 with this 
mutation had even higher HABA-binding affinity (1×10–6 M), while the 
Btn-binding affinity decreased to 2.4x10-7 M (Määttä et al., 2008). A 
decrease in affinity for Btn as a result of mutagenesis of the corresponding 
site in streptavidin had already shown similar results (Qureshi et al., 2001). 
2.5.2.2 Peptide ligands – Out of the identified natural bacterial Avds, a few 
have intrinsic peptides that bind to the Btn binding site: e.g., streptavidin 
(LeTrong et al., 2006), wt bradavidin (Leppiniemi et al., 2012) and 
hoefavidin (Avraham et al., 2015) (some examples are listed in Table 2). 
These peptide ligands have a lower binding affinity to Avds in comparison 
to Btn, but they have been instrumental for advances in the Avd-Btn 
technology through the development of commercial tags: Avi- and AviD-
tag (Gaj et al., 2007; Meyer et al., 2006), Strep-tag (a nine L-amino acid 
peptide which has affinity towards streptavidin) (Schmidt et al., 1996), 
Strep-tag II (an eight amino acid peptide) (Korndӧrfer and Skerra, 2002; 
Schmidt et al., 1996; Skerra and Schmidt, 2000, 1999; Voss and Skerra, 
1997), Nano-tag15 and Nano-tag9 (a fifteen and nine amino acid long 
peptide with streptavidin affinity, respectively)(Lamla and Erdmann, 2004; 
Perbandt et al., 2007) and SBP-tag (a thirty-eight residue long peptide with 
affinity to streptavidin)(Keefe et al., 2001). These tags are used in various 
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applications, for example, purification of fusion proteins in one-step 
procedure (Cho et al., 2000; Keefe et al., 2001; Lamla and Erdmann, 2004). 
Table 2: Examples of peptide ligands of Avds 
Tag Sequence Receptor PDB ID References  
Avi-tag DRATPY Avidin, 
NeutrAvidin 
Not 
Available 
(N.A.) 
(Meyer et al., 2006)  
AviD-tag DRATPY-spacer-
DRATPY 
Avidin, 
NeutrAvidin 
N.A. (Gaj et al., 2007)  
Nano-tag15 formyl-MDVEAW 
LGARVPLVET 
Streptavidin N.A. (Lamla and 
Erdmann, 2004)  
Nano-tag9 formyl-MDVEAWL 
GAR 
Streptavidin N.A. (Lamla and 
Erdmann, 2004)  
Nano-tag formyl-MDVEAWL Streptavidin 2G5L (Perbandt et al., 
2007)
Strep-tag AWRHPQFGG Streptavidin 1RST (Schmidt et al., 
1996)  
Strep-tag II WSHPQFEK Streptavidin; 
SA mutant 1; 
 SA mutant 2 
1RSU; 
1KL3; 
1KL5 
(Schmidt et al., 
1996) 
(Korndӧrfer and 
Skerra, 2002) 
(Skerra and 
Schmidt, 1999)  
SBP-tag MDEKTTGWRGGH
VVEGLAGELEQLR
ARLEHHPQGQREP 
Streptavidin 4JO6 (Keefe et al., 2001) (Barrette-Ng et al., 
2013)  
Brad-tag GSEKLSNTKK Bradavidin 2Y32 (Leppiniemi et al., 
2012)  
Hoef-pep 
Form A 
SVATVSESLLTE Hoefavidin 4Z2O (Avraham et al., 
2015)  
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2.5.3 Steroids – Apart from the above mentioned ligands, in recent years, 
through engineering and mutagenesis of Avds, it has been possible to shift 
the ligand binding preference of some Avds towards non-natural ligands, 
e.g. steroids, for which chicken Avd possesses no natural affinity (Riihimäki 
et al., 2011a) (see the graphical abstract, publication I). 
Steroids are a group of compounds containing a tetracyclic hydrocarbon 
sterane (Moss, 1989; Steroids, 2017). The word steroid is also used as a 
collective term for sterols, bile acids and sex hormones (Steroids, 2017). 
Steroids contain methyl groups at carbon atoms C10 and C13, and 
additional functional groups at C3 and C17 depending on the type of 
steroid (Moss, 1989) (Figure 5). 
 
Figure 5: 2D representation of (a) the steroid skeleton and (b) progesterone 
molecule. (a) Tetracyclic steroid skeleton that forms the backbone of steroids. The 
four rings are marked in black and the carbons are numbered in red. (b) The 
skeleton of the progesterone molecule for comparison. It contains a methyl group at 
position C10 and C13 and two additional functional groups at C3 and C17, 
respectively. 
 
Cholic acid, a primary bile acid for humans, is produced in the liver and 
synthesized from cholesterol. Bile acids in general are essential in dietary 
lipid absorption and cholesterol catabolism. They are also essential in 
activating cell-signaling pathways (Hylemon et al., 2009), regulating 
glucose and lipid metabolism (Li and Chiang, 2011), and preventing obesity 
and resistance to insulin in humans (Watanabe et al., 2006). 
Progesterone and testosterone are steroid sex hormones. Progesterone 
belongs to the category of progestogen sex hormones. It is essential in the 
female body, having a key role in pregnancy and menstruation (King and 
(a) (b) 
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Brucker, 2010). Apart from its role as a sex hormone, progesterone is 
essential in maintaining healthy brain activity (Roof and Hall, 2000) and 
skin (Raine-Fenning et al., 2003) in women. Testosterone belongs to the 
group of androgen sexual hormones and is essential for the development of 
male reproductive organs (Mooradian et al., 1987). It is also involved in 
maintenance of general well-being of the body. Both progesterone and 
testosterone are used in hormone replacement therapy (Bassil et al., 2009). 
Cortisol is one of the major corticosteroid (Steroids, 2017). In vertebrates, 
it is important for controlling stress responses, immune responses and 
metabolism (Charmandari et al., 2005). Cortisol (hydrocortisone) is also 
used as an anti-inflammatory drug and for suppressing extreme allergic 
reactions (Elenkov, 2004). 
2.6 (Strept)avidin-biotin technology 
The isolation and identification of Btn was clearly associated with the 
discovery of chicken Avd (Eakin et al., 1941). The extremely high affinity 
with which Btn binds to chicken Avd and streptavidin ((strept)avidin) has 
provided the basis for the widely-used technology called (strept)avidin–Btn 
technology. Since its inception, the (strept)avidin–Btn technology has led 
to major improvements in the efficiency and effectiveness of several 
biochemical and biotechnological techniques and formed the basis of 
several new technologies in various fields of biology and medical 
diagnostics. 
i) The major advantages of the strept(avidin)–Btn binding, which forms the 
underlying principle of this technology, adapted from (Wilchek and Bayer, 
1990), are listed below: 
a) The high affinity and stability of the strept(avidin)–Btn complex 
ensures tight binding between molecules and/or materials in which 
one of a pair is biotinylated and the other is coupled to 
strept(avidin) (Diamandis and Christopoulos, 1991).  
b) Btn is readily attached to most targets without altering their 
original function. 
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c) The Avd-Btn system is extremely versatile in the choice of target-
pairs it can be applied to. 
d) A wide range of different biotinylating reagents and Avd–
containing probes are available from various commercial sources 
(Wilchek and Bayer, 1990). 
ii) A few applications that implement the strept(avidin)–Btn technology are 
listed below ((Airenne et al., 1999; Laitinen et al., 2007; Wilchek and Bayer, 
1989, 1990): 
a) Isolation of Btn-tagged macromolecules and compounds is 
efficient and effective via affinity chromatography, e.g. isolation of 
biotinylated enzymes (Berger and Wood, 1975; Bodanszky and 
Bodanszky, 1970; Landman and Dakshinamurti, 1973; Rylatt et al., 
1977). 
b) Biotinylated antibodies are used for visualization and localization 
of many different compounds in affinity cytochemistry, 
immunoassays and immunohistochemistry.  
c) For study of the distribution, structure and function of cell 
surface molecules. 
d) Quantitative assays in the presence or absence of the 
corresponding antibody for a given molecule (Wilchek and Bayer, 
1989, 1990). 
e) End-point markers in the study of the mode of action of steroid 
hormones, e.g. progesterone (Hertz et al., 1944; Kohler et al., 1968; 
O’Malley, 1967). 
f) Targeting and accumulating biotinylated antibodies and 
therapeutic molecules inside tumor cells (pretargeting) (Jain and 
Cheng, 2017; Lesch et al., 2010).  
g) Biotinylated organometals attached to strept(avidin) to develop 
artificial metalloenzymes for e.g. hydrogenation (Heinisch and 
Ward, 2016). 
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In order to exploit strept(avidin)–Btn binding in an even wider set of 
applications, the properties of (strept)avidin proteins have been altered 
using protein engineering. Structural modifications (Chu et al., 1998; 
Hytönen et al., 2005b; Nordlund et al., 2004, 2005a), point mutations 
(Aslan et al., 2005; Avrantinis et al., 2002; Chilkoti et al., 1995a, 1995b; 
Dixon and Kollman, 1999; Freitag et al., 1999; Laitinen et al., 2006, 2007; 
LeTrong et al., 2003; Pazy et al., 2001; Riihimäki et al., 2011a), 
thermostability modifications (González et al., 1999; Hytönen et al., 2005a), 
increased proteolytic stability (Ellison et al., 1995), stability optimization 
over a wide range of pH (Green, 1975) and the immobilization of proteins 
using streptavidin-derived peptide tags (Hu et al., 2009) have all been 
successfully demonstrated for (strept)avidin without destroying the β-
barrel structure or their high affinity to Btn. 
The advantages of the strept(avidin)–Btn technology have obvious 
applications in bio(nano)technology. For example, for protein 
immobilization using the surface plasmon resonance technique, 
(strept)avidin has been adsorbed to a surface and used to attach 
biotinylated proteins (Hutsell et al., 2010); biotinylated nucleotides, acting 
as a scaffold for (strept)avidin and its conjugates, have been used to 
construct DNA-based nanomaterials (Li et al., 2004; Niemeyer et al., 1999; 
Park et al., 2005; Yan et al., 2003); gene detection via biotinylated DNA 
probes binding to chicken Avd attached to a sensor surface (Jin et al., 2009); 
and manipulation of the binding properties of (strept)avidin-Btn have been 
used to construct oriented biotinylated streptavidin-lipid layers 
(Blankenburg et al., 1989; Darst et al., 1991). Streptavidin-Btn complexes 
have also been used to create a molecular valve by attaching Btn to a 
nanotube (Hinds et al., 2004). Functioning nanowires have been possible 
with the help of streptavidin, which can be used to sense biotinylated DNA 
by measuring the resistance of the wire (Ramanathan et al., 2005). Avd 
attached to poly(ethyleneimine)-labelled 2-iminobiotin was used to 
generate layer-by-layer assembly (Inoue et al., 2005). Another study by 
Caswell et al. (Caswell et al., 2003) and Dimitrijevic et al. (Dimitrijevic et 
al., 2005) showed that (strept)avidin-Btn can be used as a self-assembling 
connector between nanostructures. Dual-chain (dc) Avds and single-chain 
(sc)Avds (see section 2.7.2) recognizing multiple ligand types in addition 
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to Btn have been developed with the purpose of building materials by 
linking e.g. multiple ligand-linked proteins (Leppiniemi et al., 2011).  
Due to the high alkaline pI of chicken Avd, and because it is also 
glycosylated in some systems, chicken Avd undergoes undesired 
interactions with negatively charged macromolecules. To avoid these 
issues, engineered forms of chicken Avd and neutral streptavidin have 
replaced chicken Avd in many applications, despite being a more expensive 
reagent in comparison to the native Avds (Bayer and Wilchek, 1994; 
Marttila et al., 1998, 2000; Wilchek and Bayer, 1990). 
2.7 Engineered avidins 
Due to their stable nature, small size and high affinity for Btn, Avds are 
highly amenable to genetic engineering. For example, both increased 
stability and reduced immunogenicity have been achieved (Määttä, 2010). 
The Btn-binding site in Avds is often targeted, and mutants have been 
created with altered binding affinities for Btn and for recognition of novel 
ligands, e.g. steroids (Riihimäki et al., 2011a), similar to anticalins, artificial 
lipocalins that were also engineered to bind novel ligands (Skerra, 2008). 
Avds have also been engineered to create Avd mutants with varied pIs 
(Marttila et al., 1998), changing antigenic properties, eliminating 
glycosylation sites (Hytönen et al., 2004; Marttila et al., 1998, 2000), 
lowering/eliminating affinity to Btn (Laitinen et al., 1999; Morag et al., 
1996; Reznik et al., 1998; Takakura et al., 2013), deactivating the binding 
site (Howarth et al., 2006; Määttä et al., 2008), altering the ligand specificity 
(Leppiniemi et al., 2011; Riihimäki et al., 2011a) and stability (weakened 
stability, increased protease sensitivity), lowering/increasing the melting 
temperature, and modifying the quaternary structure and topology 
(Howarth et al., 2006; Laitinen et al., 2003; Lim et al., 2013; Wu and Wong, 
2005); discussed in (Laitinen et al., 2006). 
2.7.1 Chimeric avidins – Chimeric Avds were designed by picking a part 
of one Avd and merging it with another Avd, with properties from both of 
the parent Avds. For example, chimeric streptavidin tetramers combining 
wt streptavidin with genetically engineered streptavidin (N49C, H127C or 
W120A mutant) subunits were constructed by Chilkoti et al. in 1995 
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(Chilkoti et al., 1995b) to be utilized as tools for bioseparation and drug 
delivery. Hytӧnen et al. created a chimeric Avd (ChiAVD), where the 
chicken Avd β4 strand and its adjoining loops were replaced with the 
corresponding section from AVR4, to combine the high affinity Btn-
binding properties of Avd with higher thermostability of AVR4 (Hytönen 
et al., 2005a). Since then, several chimeric Avds have been created and 
studied by Prof. Emeritus Kulomaa’s and Assoc. Prof. Hytӧnen’s lab 
(Määttä et al., 2011; Riihimäki et al., 2011b; Taskinen et al., 2014). 
2.7.2 Circularly permuted avidins (cpAvds) – The influence of the loops 
to the ligand affinity of (strept)avidin has been carefully studied (Pazy et al., 
2002), and a decrease in Btn-binding affinity of streptavidin by L3,4 loop 
deletion was already shown in an earlier study by (Chu et al., 1998; Ellison 
et al., 1995). These flexible loops regulate the ligand/solvent traffic inside 
the binding site with ‘open’ and ‘close’ loop conformations: the open loop 
conformation leads to ligand binding, and the closed loop conformation 
prevents solvent access, and minimizes ligand dissociation. For example, in 
streptavidin, the shorter L3,4 loop, the longer L5,6 loop, and the absence of 
a few H-bonds due to the difference in Btn-binding residues, have been 
shown as the major reasons for streptavidin’s weaker Btn-binding affinity 
in comparison to chicken Avd. The HABA-binding affinity is also likely to 
be affected by the same structural differences within (strept)avidin (Green, 
1990; Repo et al., 2006).  
Two circularly permuted forms of chicken Avd (cpAvd5→4 and cpAvd6→5) 
have been designed by Nordlund and co-workers, where the original N- 
and C-termini were connected to each other via a linker and the L4,5 loop 
for cpAvd5→4 and L5,6 loop for cpAvd6→5 were cleaved to create the new 
termini (Nordlund et al., 2004) (see below). Similarly, Määttä and co-
workers, created cpAvd4→3 by cleaving the L3,4 loop of chicken Avd, and 
the original N- and C- termini were joined via a linker. The cpAvd4→3 
protein had significantly reduced Btn-binding affinity (Kd~1.4±0.3×10–8 
M) and a 1.5 fold increase in its HABA-binding affinity (Kd~5.4±0.7×10–6 
M) (Määttä et al., 2008). 
2.7.2.1 Dual chain avidins (dcAvds) – Nordlund and coworkers 
(Nordlund et al., 2004) created cpAvds (cpAvd5→4 and cpAvd6→5) with 
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two distinct and independently modifiable ligand-binding sites held 
together in one polypeptide chain. The original N- and C- termini of the 
Avd, in both the cpAvds, were joined via a six residue linker (GGSGGS), 
while the new C-terminus of cpAvd5→4 was joined with the N-terminus of 
cpAvd6→5 via a three residue linker (SGG) to join the two different cpAvds 
in a single polypeptide chain to create a dual chain Avd (dcAvd). The N- 
and C- termini of the dcAvd were positioned close to each other in the 3D 
structure. This technique makes it possible to use two independent Avd 
subunits with variable binding affinities for different ligands, and connect 
them via a single polypeptide chain to create a dcAvd with two distinct 
binding sites. The dcAvd proteins have a β-barrel structure and dimerize, 
forming a structure similar to tetrameric Avds although slightly less stable. 
When the binding sites correspond to that in chicken Avd, the Btn-binding 
affinities are similar to that for chicken Avd (Figure 6).  
2.7.2.2 Single chain avidins (scAvds) – Nordlund and coworkers in 2005 
(Nordlund et al., 2005a) also created circular permutants in which two 
dcAvds were joined together by a twelve-residue peptide linker forming a 
single chain Avd (scAvd) (Figure 6). Thus, four independently modifiable 
binding sites were joined together in a single polypeptide chain and the 
scAvds had similar binding affinities and thermal stability to the dcAvds 
(Nordlund et al., 2005a). The approach was used to combine the binding 
sites from various Avds into the same polypeptide chain, constructing a 
protein binding two or more ligands or even with different affinities for the 
same ligand (Nordlund et al., 2005a). A similar approach has also been 
applied to modifications of streptavidin (Aslan et al., 2005). 
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Figure 6: Engineering strategy of dual chain (dc) and single chain (sc) Avds from 
(Laitinen et al., 2007). (a) Chicken Avd topology (i), its tertiary (ii) and quaternary 
structure (iii). (b) Two circularly permuted mutants were generated by: one with the 
new termini between L4,5 loop region (upper chain saw, cpAvd5→4); and the other 
between L5,6 loop region (lower saw, cpAvd6→5). Both cpAvds had four identical 
subunits. (c) The C-terminus of cpAvd5→4 was joined to the N-terminus of 
cpAvd6→5 to generate a dcAvd. These dcAvds can combine to form two different 
quaternary structures or can be modified to have subunits from different Avds. (d) 
Two dcAvds were fused together to generate a scAvd, which consists four 
independently modifiable domains usable to combine other Avds with different 
ligand-binding properties. Reprinted with permission from Elsevier. 
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2.7.3 Steroid-binding avidins (sbAvds) – Riihimäki and coworkers in 
2011 (Riihimäki et al., 2011a) started development of chicken Avd-based 
mutants, capable of binding steroids. The steroid-binding sbAvd-1 and 
sbAvd-2 were chosen from phage display (Smith, 1985) selection and 
panning against testosterone. For sbAvd-1, Riihimäki and coworkers 
(Riihimäki et al., 2011a) constructed a phage display library, Avd L1,2, 
where the residues of the L1,2 loop region of chicken Avd were allowed to 
be randomly replaced by other amino acids. The sbAvd-1 carried the 
mutations D13R, L14M, G15N, and S16H in the L1,2 loop. To further 
reduce the Btn-binding affinity of sbAvd-1, another library, sbAvd-1 L3,4, 
was constructed where the residues of L3,4 loop in sbAvd-1 were allowed 
to be randomly replaced with other amino acids except tryptophan, 
glutamine, glutamate, methionine and lysine. The sbAvd-1 variant, sbAvd-
2, carried additional mutations T35A, A36T, and T38N in the L3,4 loop 
regions along with the L1,2 loop region mutations from sbAvd-1; sbAvd-2 
showed clear binding to testosterone and progesterone along with a 
reduced binding affinity to Btn in a microplate assay (Riihimäki et al., 
2011a). In addition, unlike sbAvd-1, free Btn did not affect the binding of 
testosterone and progesterone to sbAvd-2 (Riihimäki et al., 2011a). 
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3. Aims of the study 
The aim of this study was to determine the X-ray structures of natural and 
engineered Avds that recognize ligands other than Btn in order to elucidate 
the structural and functional features responsible for ligand recognition. 
These ligands included peptide ligands, steroids and other small molecules. 
These novel Avds will be helpful in developing and designing novel protein 
scaffolds for modern bio(nano)technological applications. 
 
The specific aims of this study are as follows: 
 
I. To characterize the molecular structure of novel, artificial, chicken 
Avd -based receptors, termed “antidins” that bind non-Btn ligands, 
such as steroids (publication I, manuscript II). 
II. To analyze the binding of selected antidins with novel ligands e.g. 
progesterone, through computational molecular docking 
(manuscript II). 
III. To characterize the molecular structure of core-bradavidin in 
complex with Btn, and produce computational models of other 
native, non-chicken Avd based Avds, e.g. rhodavidin and 
bradavidin A2, which also have the Brad-tag sequence at their C-
terminus (publication III).  
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4. Materials and methods 
The materials and methods, summarized below, are described in detail in 
publication I, III and manuscript II. 
4.1 Crystallization and data collection (I, II, III) 
Crystals (I, II, III) were obtained using the sitting drop vapor diffusion 
method (McPherson, 1982). Drops with varying proportions of protein 
solution and screening solutions were prepared with the mosquito® liquid 
handling robot (TTP Labtech) for the apo-form (I) and the progesterone 
bound sbAvd-2 (I117Y) form (II), and manually for the core-bradavidin–
Btn complex (III). The crystals used for data collection typically appeared 
within a few weeks of incubation at 21°C in the temperature-controlled 
incubator (RUMED® model 3201). The crystals were initially analyzed 
using a PX Scanner (Agilent Technologies) (I, II) to check for diffraction 
and salt crystal detection. For data collection, cryoprotectant (CryoProtX™, 
Molecular Dimensions) for (I, II) and 100% glycerol for (III) was added to 
the crystallization drop just prior to fishing them out from the 
crystallization drop and freezing in liquid nitrogen. Data were collected at 
the European Synchrotron Radiation Facility (ESRF), Grenoble, France (I, 
II) and MAX-LAB, Lund, Sweden (III). 
4.2 Structure determination and refinement (I, II, III) 
Data were processed using XDS (Kabsch, 1993). Molecular replacement 
was made using Phaser (McCoy et al., 2007) within CCP4i (Potterton et al., 
2003; Winn et al., 2011), producing the initial phase estimates for the 
structure factors (I, II, III). The space group of the apo-form as well as 
ligand-bound sbAvd-2 (I117Y) mutant structures were confirmed to be 
P21212 (I, II), and that of the core-bradavidin–Btn complex was confirmed 
to be P212121 (III). The initial refinement of the structures was done with 
Refmac5 (Murshudov et al., 2011) and then manual editing used Coot 
(Emsley and Cowtan, 2004), including addition of water and ligand 
molecules. Solvent atoms were added using ARP/wARP (Lamzin and 
Wilson, 1993; Langer et al., 2008; Morris et al., 2003; Perrakis et al., 1999) 
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and later manually in Coot (Emsley and Cowtan, 2004) (I, II, III). A few 
refinement cycles for core-bradavidin–Btn complex were also done in 
Phenix (Adams et al., 2002, 2010; Zwart et al., 2008) (III). Coot (Emsley and 
Cowtan, 2004) and MolProbity (Davis et al., 2007) were used to validate the 
final structure (I, II, III). PyMOL (Schrӧdinger, 2010) and Bodil (Lehtonen 
et al., 2004) were used for visualization. Final structure coordinates and 
structure factors were deposited into Protein Data Bank (Berman et al., 
2000, 2002) with PDB codes 4U46 (sbAvd-2 (I117Y), at 1.95 Å resolution) 
(I), 5LUR (sbAvd-2 (I117Y) in complex with progesterone, at 2.8 Å 
resolution) (II) and 4BBO (core-bradavidin in complex with Btn, at 1.60 Å 
resolution) (III). 
4.3 Homology modelling (II, III) 
All protein sequences were retrieved from the NCBI sequence database 
(http://ncbi.nlm.nih.gov/). The crystal structure coordinates used as 
templates – the sbAvd-2 (I117Y)–progesterone complex structure 
[PDB:5LUR] and the Avd-Btn complex structure [PDB: 1AVD] for two 
different sets of models for sbAvd-7–9 (II) and the wt bradavidin structure 
[PDB:2Y32] for rhodavidin and bradavidin A2 (III) – were obtained from 
the PDB (Berman et al., 2000, 2002). Structure-based sequence alignments 
were made using Malign (Johnson and Overington, 1993) in Bodil 
(Lehtonen et al., 2004) and later formatted for use by Modeller 9.14 (Sali 
and Blundell, 1993) to perform the model building. Ten tetrameric models 
were created for each protein that were internally ranked by Modeller using 
Molecular PDF (molpdf) score and Discreet Optimized Protein Energy 
(DOPE) scoring system. MolProbity (Davis et al., 2007) was also used to 
check geometrical and structural parameters. The Ramachandran plot was 
observed for each model and more than 96% of all the residues were in the 
favored regions of the plot. Structure visualization was made via PyMol 
(Schrӧdinger, 2010). Final structure selection was done based on visual 
analysis and the results of the Ramachandran plot. 
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4.4 Molecular docking (II) 
Ligands were docked in Maestro 11.3 of the Schrödinger suite (Schrödinger 
Release 2017-3: Maestro, Schrödinger, LLC, New York, NY, 2017). Ligands 
were imported from the NCBI PubChem database (https:// 
pubchem.ncbi.nlm.nih.gov/) along with the model structure (sbAvd-7–9) 
and the experimentally determined sbAvd-2 (I117Y) crystal structure (with 
a modeled L3,4 loop region and no progesterone). The protein preparation 
wizard application in Maestro 11.3 was used for protein structure 
optimization and energy minimization using the force field OPLS_2005. 
Ligands were minimized by the LigPrep application using the OPLS_2005 
force field in Maestro 11.3. Protein-ligand docking was performed by the 
Induced Fit Docking (IFD) application (Farid et al., 2006; Sherman et al., 
2006a, 2006b) in Maestro 11.3. 
4.5 PCA and variance analysis (II) 
The conformations of different poses of the docked ligands were compared 
to each other using principal component analysis (PCA). The distances of 
each poses from one another were input into a set of C programs (fixrmsd; 
PCA, MS Johnson). The distances for all pairs of poses were calculated as 
the RMSD of their coordinates. The PCA program output the points as a 
PDB-style coordinate file where each point corresponded to a pose. The 
program displayed each point such that the variance among the data is a 
maximum. The data were displayed within the most informative three 
dimensions determined by the three largest eigenvalues. The PDB file was 
visualized in Bodil (Lehtonen et al., 2004). 
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5. Results 
The results summarized below present the author’s contribution in the 
publications I-III from the closely collaborative project. 
5.1 Structure of steroid-binding avidin (sbAvd)-2 (I117Y) (I, 
II) 
5.1.1 Structure of apo sbAvd-2 (I117Y) (I) 
We have determined the X-ray structure of a novel, steroid-binding Avd 
mutant, sbAvd-2 (I117Y), at 1.95 Å resolution (Table 4, publication I, for 
structure determination statistics) [PDB:4U46] in the ligand-free apo form 
(Figure 7). The crystal used for data collection had two monomers per 
asymmetric unit, but the protein assembly was tetrameric. The sbAvd-2 
(I117Y) structure was designed based on chicken Avd and, despite 
containing major differences in the L1,2 and L3,4 loop regions as a result 
of selection from a phage display library (see below), the sbAvd-2 (I117Y) 
structure retained the β-barrel structure characteristic of all Avds.  
Owing to the importance of the L1,2 and L3,4 loops in chicken Avd–Btn 
binding, these loop regions were selected by our collaborators (Prof. 
Emeritus Markku Kulomaa’s and Assoc. Prof. Vesa Hytönen’s research 
groups), for creating phage display gene libraries, where the loop residues 
were randomly replaced by other amino acids. The first library consisted of 
randomized residues over the L1,2 loop; the second library consisted of 
randomized residues for the L3,4 loop. Steroid binding Avds were 
identified from the libraries by phage display panning against a 
testosterone-coated surface. The chicken Avd variant, sbAvd-2, selected for 
lower Btn binding and higher progesterone binding, had the following 
mutations: D13R, L14M, G15N and S16H in the L1,2 loop region and 
T35A, A36T and T38N in the L3,4 loop region (Riihimäki et al., 2011a). 
Additionally, a site-directed mutation, I117Y, proposed on the basis of 
Tyr115 in AVR4 (Hytӧnen et al., 2004), was introduced into the β8 strand 
of sbAvd-2 to increase thermostability. 
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Figure 7: X-ray structure of apo sbAvd-2 (I117Y) [PDB:4U46] (publication I). 
The tetrameric structure of the sbAvd-2 (I117Y) is shown with transparent surface. 
The Tyr117 residues at the interface are shown as black sticks and the His16 residues 
inside the binding site are shown as black spheres. The subunits of the tetramer are 
colored cyan (subunit 1), green (subunit 2), magenta (subunit 3) and yellow 
(subunit 4). Reprinted with permission from American Chemical Society. 
 
Residues Asn38-Asn42 of the L3,4 loop in sbAvd-2 (I117Y) could not be 
built into the crystal structure due to non-interpretable electron density 
arising from high thermal motion of the flexible loop. Unlike the chicken 
Avd-Btn complex structure [PDB: 2AVI, 1AVD] (Livnah et al., 1993a; 
Pugliese et al., 1993), where the L3,4 loop adopts a ‘closed’ conformation, 
acting as a lid to seal the Btn inside the binding site, the L3,4 loop in sbAvd-
2 (I117Y) adopts an ‘open’ conformation, which was attributed to the 
absence of a ligand in the ligand binding site (Figure 4B, publication I). In 
Results 
37 
comparison to Ile117 in sbAvd-2, the engineered Tyr117 mutation, present 
at the interface in sbAvd-2 (I117Y) is involved in π-π stacking with Tyr117 
of the neighboring subunit. Tyr117 also forms two H-bonds: one with the 
side chain of Lys94 of the neighboring subunit and another with a nearby 
water molecule, thereby increasing the thermostability of the sbAvd-2 
(I117Y) mutant by ~ 15°C in comparison to sbAvd-2. 
In the sbAvd-2 (I117Y) apo form, two mutations – T35A in the L3,4 loop 
and S16H in the L1,2 loop – were hypothesized to be important for reduced 
Btn-binding affinity (Kd~10-9 M). In chicken Avd, Thr35 is H-bonded to 
the N3ʹ nitrogen atom of the ureido ring and Ser16 is H-bonded to the 
oxygen atom of the ureido ring of the Btn ligand. During superimposition 
of the structure of chicken Avd [PDB:1AVD] with the structure of the 
sbAvd-2 (I117Y) apo form [PDB:4U46], it was observed that the H-bonds 
formed by Thr35 and Ser16 in chicken Avd would have been missing in 
sbAvd-2 (I117Y) due to the mutations T35A and S16H. Moreover, Ala35 
created a more hydrophobic environment inside the binding site of the 
sbAvd-2 (I117Y) protein that would make it less suitable for the ureido ring 
of an incoming Btn, and the imidazole side chain of His16 protruded inside 
the binding site partially occupying a space equivalent to the ureido ring 
oxygen atom of Btn (Figure 4C, publication I). 
5.1.2 Structure of sbAvd-2 (I117Y)–progesterone complex (II) 
We also determined the X-ray structure of sbAvd-2 (I117Y) in complex 
with progesterone at 2.8 Å resolution (Table 1, manuscript II) [PDB:5LUR] 
using a co-crystallization method. The complex structure of the sbAvd-2 
(I117Y) protein has, as expected based on the apo structure, the 
characteristic β-barrel structure of Avds, with a progesterone ligand bound 
to each monomer; there were two monomers in the asymmetric unit of the 
crystal, but the assembly was clearly tetrameric, similar to the apo structure 
(Figure 8). 
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Figure 8: X-ray structure of the sbAvd-2 (I117Y)-progesterone complex 
[PDB:5LUR]. The tetrameric structure of sbAvd-2 (I117Y) with bound 
progesterone is shown with transparent surface. The progesterone ligands inside the 
binding sites are shown as black spheres (carbon atoms). The four subunits are 
colored green (subunit 1), magenta (subunit 2), cyan (subunit 3) and yellow 
(subunit 4). The oxygen atoms of the progesterone ligands are colored red. 
 
The progesterone-binding mode of the sbAvd-2 (I117Y) crystal structure 
was different from our earlier hypothesis, which was based on automated 
docking of progesterone to sbAvd-2 (I117Y). In the docking analysis, the 
A-ring of the progesterone ligand (Figure 5a) faced the hydrophobic core 
of the binding site, and the L3,4 loop adopted a ‘closed’ conformation to 
seal and stabilize the ligand inside the binding site. However, in the crystal 
structure, the progesterone ligand enters the ligand-binding site ‘D-ring 
first’ – the oxygen atom of the 20-acetyl group of progesterone forms H-
bonds with the Asn118 Nδ (2.4 Å) and Trp97 Nε (3.0 Å) atoms; the critical 
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His16 and Ala35 residues were involved in hydrophobic interactions with 
progesterone, along with Met14, Tyr33, Val37, Trp70, Phe72, Thr77, Phe79 
and Trp110 (from the neighboring subunit) (Figure 3, manuscript II). In 
contrast with the results from automated ligand docking, the L3,4 loop of 
the sbAvd-2 (I117Y) complex structure clearly adopted an ‘open’ 
conformation, even though residues Asn38-Ser41 of this loop could not be 
built into the electron density due to high thermal motion. 
The L1,2 loop in progesterone-bound sbAvd-2 (I117Y), crucial for ligand 
binding in all Avds, showed clear changes in conformation compared to 
the apo sbAvd-2 (I117Y) structure [PDB: 5LUR vs. 4U46]. In comparison 
with apo sbAvd-2 (I117Y), the His16 side chain of the progesterone-bound 
sbAvd-2 (I117Y) structure relocated to stabilize the incoming progesterone 
ligand and the conformation and position of the side chains of Arg13, 
Asn15 and Asn17 also altered, although these residues did not directly 
affect ligand binding. The Met14 side chain moved towards the binding site 
by 5.5 Å in order to bind the progesterone ligand (Figure 2, manuscript II). 
Unlike in the case of the apo sbAvd-2 (I117Y) [PDB:4U46], the electron 
density for the L1,2 loop region of sbAvd-2 (I117Y)–progesterone complex 
[PDB:5LUR] was clearly interpretable indicating that the progesterone 
ligand stabilized the conformation of the L1,2 loop. Unfortunately, the 
Tyr117 mutation, added to improve the thermostability of the protein and 
located at the IF1,3 interface, was found to lower the binding affinity of the 
sbAvd-2 (I117Y) antidin to progesterone in a fluorometric assay. The direct 
effect of this mutation for the structure was not clear; however, Tyr117 
could indirectly affect the progesterone binding by altering the 
conformation/location of the next residue, Asn118, which forms a H-bond 
with the progesterone ligand in the sbAvd-2 (I117Y) complex structure. 
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5.2 Docking studies on selected antidins (II) 
Our collaborators (Prof. Emeritus Markku Kulomaa’s and Docent Vesa 
Hytönen’s research groups), in collaboration with our laboratory 
(structural analysis), have developed a number of artificial, chicken Avd-
based antidins. In comparison to chicken Avd, these antidins contained 
major differences in their loop regions near the ligand-binding site; a few 
antidins contained additional mutations of other residues, too (see Table 2, 
Publication I; Table 2, manuscript II for a list of all the mutated residues in 
the studied antidins). All of the studied antidins were tested for their 
binding affinity with progesterone and Btn using a fluorometry-based 
assay. Based on the results of this assay, we selected three high-affinity 
progesterone binders (Table 3) – sbAvd-7 (Kd~5 nM), sbAvd-8 (Kd~11 
nM), sbAvd-9 (Kd~13nM) – which we modeled (details in section 5.4) and 
docked Btn and progesterone in order to gain insight on their possible 
ligand-binding modes at the atomic level.  
After the structural characterization of the sbAvd-2 (I117Y)–progesterone 
complex structure, we expected that the sbAvds having the same mutations 
in the L1,2 loop region – Arg13, Met14, Asn15, His16 (RMNH) – should 
have a similar binding mode, progesterone entering the ligand-binding site 
‘D-ring first’ and the L3,4 loop adopting an open conformation. In 
accordance with these assumptions, our docking analysis showed that four 
out of eleven (sbAvd-7), six out of eight (sbAvd-8) and seven out of sixteen 
(sbAvd-9) progesterone poses were docked in a similar orientation and 
depth as the progesterone was observed in the ligand-bound sbAvd-2 
(I117Y) crystal structure (Figure 5, manuscript II).  
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Table 3: List of mutations in the selected high-affinity progesterone binders, 
in comparison to chicken Avd structure [PDB:1AVD] and the sbAvd-2 
(I117Y)–progesterone complex structure [PDB:5LUR].  
Chicken  
Avd 
Sbavd-2  
(I117Y) 
Sbavd-7 Sbavd-8 Sbavd-9 
D13 R R R R 
L14 M M M M 
G15 N N N N 
S16 H H H H 
Y33 - - F - 
T35 A A - Y 
A36 T S Y Y 
V37 V L S L 
T38 N N Y P 
T77 - A A A 
I117 Y - - - 
 
Despite extensive visual analysis of the ligand poses in the docking 
complexes, we were not able to completely explain the difference in the 
binding affinities of sbAvd-7, sbAvd-8 and sbAvd-9, in comparison to 
sbAvd-2 (I117Y) and each other, at the atomic level. In each of the antidins 
sbAvd-7–9, varying interaction networks were observed for every 
progesterone pose in each docked complex. The potential hydrophobic/van 
der Waals interactions, were not trivial to predict despite the unique set of 
mutations in the L3,4 loop region in each of the antidins sbAvd-7–9. As a 
reference, we manually removed the ligand from the crystal structure of the 
sbAvd-2 (I117Y)–progesterone complex [PDB:5LUR] and docked it back 
into the ligand-binding site – even in that case, the docking poses produced 
were different to the ligand pose observed in the crystal structure, 
indicating the challenges of docking a pseudo-symmetrical steroid, such as 
progesterone in an Avd-like binding pocket and/or the limitations of the 
state-of-the-art docking programs.  
In the case of Btn docking with sbAvd-7–9, we observed that the His16 
residue inside the binding pocket clearly hindered Btn binding in these 
antidins. This was in agreement with our earlier prediction after the 
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analysis of the sbAvd-2 (I117Y) complex structure, that His16 in the L1,2 
loop is one of the key residues to reduce Btn-binding. In addition to the 
role of His16, the mutations in the L3,4 loop further reduced the Btn-
binding affinity of sbAvd-7–9. For example, in the case of sbAvd-9, a bulky 
tyrosine residue at position 35 extending directly inside the ligand-binding 
site restricted the entry of Btn. 
5.3 Structure of core-bradavidin–biotin complex (III) 
Bradavidin is a tetrameric protein isolated from the nitrogen-fixing 
bacterium Bradyrhizobium diazoefficiens (Delamuta et al., 2013; Nordlund 
et al., 2005b). Wild-type bradavidin is 138 amino acids in length, and its C-
terminal residues 129GSEKLSNTKK138, known as the ‘Brad-tag’, acts as an 
intrinsic peptide ligand that binds to the ligand-binding site of the adjacent 
subunit in the tetramer, as was recently detailed in our laboratory by 
determining the X-ray structure of wt bradavidin (Leppiniemi et al., 2012). 
Engineered core-bradavidin lacks the C-terminal residues Gly114-Lys138, 
thus removing the Brad-tag (Gly129-Lys138). In publication III, we 
reported the X-ray crystal structure of the core-bradavidin–Btn complex at 
1.60 Å resolution (Figure 9) [PDB:4BBO] (Table 1, publication III for 
structural determination statistics). Despite the low sequence similarity – 
35% percent identity – between chicken Avd and core-bradavidin, most of 
the Btn-binding residues are conserved in core-bradavidin (Figure 10). The 
exceptions include Asp107 (Asn118 in chicken Avd) and Asn33 residues 
(Thr35 in chicken Avd).  
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Figure 9: X-ray structure of the core-bradavidin-Btn complex [PDB:4BBO]. The 
tetrameric structure of core-bradvidin with bound progesterone is shown with 
transparent surface The Btn ligand found in all the four binding sites of the 
tetrameric structure is shown as black spheres (carbon atoms). The four subunits are 
colored yellow (subunit 1), cyan (subunit 2), magenta (subunit 3) and green 
(subunit 4). The nitrogen atoms are colored blue, oxygen atoms red and sulfur atoms 
yellow.  
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Figure 10: Comparison of the Btn-binding residues of core-bradavidin 
[PDB:4BBO] (orange carbon atoms, bold labels) and chicken Avd [PDB:1AVD] 
(cyan, labels in brackets) presented as a stereo view (publication III). The Cα 
traces of both the structures were superimposed. Trp99 (Trp110 in chicken Avd) is 
shown from the neighboring subunit, other residues are from subunit 1. The bound 
Btn ligands are shown as sticks. Nitrogen atoms are colored blue, oxygen atoms red 
and sulfur atoms yellow. Water molecules are shown as red spheres. H-bonds are 
drawn as grey dashed lines and distances are in Ångströms. (*=2.8 Å). Reprinted 
with permission from PLOS ONE. 
 
The major structural difference between the wt bradavidin structure and 
the core-bradavidin structure is in the L3,4 loop region. In wt bradavidin, 
the L3,4 loop adopts an ‘open’ conformation in order to accommodate the 
bulkier Brad-tag (Figure 11). In contrast, in the core-bradavidin–Btn 
complex structure, the L3,4 loop adopts a ‘closed’ conformation, sealing 
Btn within the binding site. Hence, residues of the L3,4 loop, including 
Ser38, Cys39, Asp40 and Glu41, undergo major structural/conformational 
changes in the core-bradavidin structure in comparison to wt bradavidin 
structure (Figure 7, publication III). 
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Figure 11: Comparison of the L3,4 loop of core-bradavidin [PDB:4BBO]  
(subunit 1, orange) and wt bradavidin [PDB:2Y32] (subunit 1, magenta; 
subunit 3, green). The Cα traces of both the structures were superimposed. Nitrogen 
atoms are colored blue, oxygen atoms red and sulfur atoms yellow.  
 
A disulphide bridge near the Btn binding site is a feature commonly 
observed in the dimeric Avds, for example, rhizavidin (Meir et al., 2009), 
hoefavidin (Avraham et al., 2015), shwanavidin (Meir et al., 2012) and 
bradavidin II (dimeric and tetrameric forms) (Leppiniemi et al., 2013). The 
disulphide bridge helps stabilize the ligand-binding site. Bradavidin is the 
first tetrameric Avd reported to have a disulphide bridge, Cys39 (L3,4 loop) 
– Cys69 (L5,6 loop), located near the binding site (Leppiniemi et al., 2012). 
In core-bradavidin, the Cys39 residue is not structurally equivalent to the 
cysteine residue observed in the dimeric Avds (Figure 12), whereas the 
other cysteine residue, Cys69, is structurally conserved even though the 
L5,6 loop conformation in rhizavidin, hoefavidin, shwanavidin, and 
bradavidin II is different. In wt bradavidin, the conformation of the side 
BTN 
Brad-tag 
L3,4 loop of 
wt bradavidin 
L3,4 loop of core-
bradavidin  
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chain of Cys39 changes to assist in the ‘opening’ of the L3,4 loop in order 
to accommodate the Brad-tag. The Asp40 residue also seems to play an 
important role in this regard – the side chain of Asp40 is flipped in wt 
bradavidin, in comparison to core-bradavidin (Figure 5, publication III). 
Thus, besides the possible role of the disulphide bridge in tetrameric 
bradavidin in stabilizing the binding site, it also appears to have a role to 
aid opening/closing of the L3,4 loop during ligand binding.  
 
 
Figure 12: Disulphide bridge in the ligand-binding site of core-bradavidin 
[PDB:4BBO] (orange carbon atoms), rhizavidin [PDB:3EW2] (red), 
shwanavidin [PDB:3SZJ] (magenta), bradavidin 2 [PDB:4GGZ] (green) and 
hoefavidin [PDB:4Z28] (blue). The Cα traces of subunit 1 were superimposed. The 
sulfur atoms are colored yellow.  
5.4 Homology models of natural and engineered avidins (II, 
III) 
The structures of several artificial antidins, based on chicken Avd, were 
modeled because we did not have their experimental structures; the models 
were used to visualize the consequences of the differences with chicken Avd 
and for the docking studies (II). We created two different set of models for 
each of the antidins sbAvd-7–9: one for docking progesterone, having an 
open L3,4 loop conformation, similar to the sbAvd-2 (I117Y)–
progesterone complex structure [PDB:5LUR], and the other for docking 
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Btn, having a closed L3,4 loop conformation similar to the chicken Avd 
structure [PDB:1AVD]. 
In the case of the sbAvd-7–9 models for progesterone docking, the template 
used was the sbAvd-2 (I117Y)-progesterone complex structure 
[PDB:5LUR], in which the missing L3,4 loop residues were modeled in an 
open conformation. The sbAvd-2(I117Y)-progesterone complex structure 
[PDB:5LUR] provided details for the L1,2 loop region, which were similar 
in all three studied antidins, and for the L3,4 loop region, which was 
expected to be in an open conformation while binding progesterone.  
For the sbAvd-7–9 models used for docking Btn, we used two templates: 
the chicken Avd structure [PDB:1AVD], and the L1,2 loop region from the 
sbAvd-2 (I117Y)–progesterone complex structure [PDB:5LUR]. Because 
Btn inside the Avd-binding site prefers to interact with the residues of the 
L3,4 loop in a ‘closed’ conformation, we used chicken Avd as the template, 
which has a closed L3,4 loop region while binding Btn. However, owing to 
the identical mutations – D13R, L14M, G15N and S16H – in the L1,2 loop 
region of sbAvd-7–9 and the sbAvd-2 (I117Y) structure [PDB:5LUR], we 
modeled the L1,2 loop region based on the ligand bound sbAvd-2 (I117Y) 
crystal structure (II). 
In order to learn more about the mode of Brad-tag binding in other Avds 
containing the Brad-tag sequence, two structures were modeled using wt 
bradavidin as the template [PDB: 2Y32]: rhodavidin from 
Rhodopseudomonas palustris (Larimer et al., 2004) and bradavidin A2 from 
Bradyrhizobium sp. Ai1a-2 (III) (Figure S2, publication III). The 
rhodavidin and bradavidin A2 proteins are respectively 75% and 74% 
identical in sequence to bradavidin; both have an extended linker region 
between their β8-strand and the Brad-tag. Additionally, two residues in 
bradavidin A2 differ from bradavidin within the Brad-tag region: Ala131 
(Gly129 in wt bradavidin) and Gly132 (Ser130 in wt bradavidin). In the 
modeled structures, these differences are unlikely to affect Brad-tag binding 
to rhodavidin and bradavidin A2 significantly, but they have not been 
tested experimentally. 
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6. Discussion 
Streptavidin and chicken Avd, collectively known as strept(avidin), bind to 
Btn with one of the highest observed affinity for a ligand via non-covalent 
interactions; indeed, the dissociation constant for chicken Avd is Kd~10-15 
M (Green, 1975). Strept(avidin) is also extremely stable against heat, pH 
and other denaturants (González et al., 1999; Green, 1975; Hytönen et al., 
2005a). These properties form the basis of the strept(avidin)-Btn 
technology, which is utilized in a plethora of life science applications to 
purify, label, separate and target proteins, peptides and other molecules. In 
order to extend the range of applications utilizing this technology, 
strept(avidin) has been modified both chemically as well as genetically 
(Laitinen et al., 2006, 2007). 
Even though the four (or two in dimeric Avds) binding sites of the Avds 
have a highly complementary fit to the Btn ligand, some Avds also bind 
non-Btn ligands, such as Btn analogs, azocompounds, and peptide ligands, 
all with reduced affinity in comparison to Btn. In this thesis, we focus on 
natural Avds binding intrinsic peptide ligands as well as artificial Avds, 
‘antidins’, having tailored binding sites for steroids. Because dc and sc Avds 
have been engineered, binding observed towards non-Btn ligands could be 
incorporated as separate binding sites on two polypeptide chains or on a 
single polypeptide, yielding an Avd capable of simultaneously binding up 
to two (dc) or four (sc) different ligands, respectively. Such Avds could be 
utilized in various applications in bio(nano)technology where 
simultaneous recognition of multiple ligands is beneficial, for example in 
diagnostic applications. 
6.1 Natural avidins binding peptide ligands 
The binding of an intrinsic peptide ligand naturally in the Btn-binding site 
of Avds is an uncommon mechanism, currently observed in only a few 
prokaryotic Avds – tetrameric Avds: streptavidin (Streptomyces avidinii) 
(LeTrong et al., 2006) and bradavidin (Bradyrhizobium diazoefficiens) 
(Delamuta et al., 2013; Nordlund et al., 2005b); and dimeric Avds: 
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rhizavidin (Rhizobium etli) (Meir et al., 2009) and hoefavidin (Hoeflea 
phototrophica) (Avraham et al., 2015). 
For example, in wt bradavidin, the C-terminal Brad-tag (Gly129-Lys138) 
acts as an intrinsic peptide ligand by attaching itself to the Btn-binding site 
of the neighboring subunit and vice versa [PDB:2Y32] (Leppiniemi et al., 
2012). Core-bradavidin was engineered to remove the C-terminal residues 
Gly114-Lys138, which includes the Brad-tag sequence, from wt bradavidin. 
In publication III, we reported the structure of core-bradavidin in complex 
with Btn [PDB:4BBO] at 1.60 Å resolution. With the characterization of the 
core-bradavidin–Btn complex [PDB:4BBO], and the previously 
determined wt bradavidin–Brad-tag complex [PDB:2Y32], we now have 
two bradavidin crystal structures detailing the binding mode of two very 
different ligands of this Avd. 
The two bradavidin crystal structures [PDB: 4BBO and 2Y32] were visually 
characterized on a graphical 3D workstation and using computational tools 
to identify major differences undertaken by bradavidin in order to bind both 
the Brad-tag and Btn. In core-bradavidin, the L3,4 loop adopted a ‘closed’ 
loop conformation to bind Btn, whereas, in wt bradavidin, the L3,4 loop 
adopted an ‘open’ loop conformation to bind the bulkier Brad-tag sequence. 
A clear conformational change in the Cys39 side chain is observed between 
wt bradavidin and core-bradavidin, suggesting a possible role for the 
disulphide bridge (Cys39-Cys69) in enabling differential ligand binding. To 
test this possibility, we mutated Cys39 and Cys69 to alanine residues (core-
bradavidin CC mutant). However, we did not observe any significant 
differences on Btn-binding between core-bradavidin and the CC mutant. 
Although Brad-tag binding could not be tested experimentally, the low yield 
of the CC mutant hints at a possible role of the disulphide bridge in protein 
folding. Another core-bradavidin variant, core-bradavidin V1, was designed 
to mask the hydrophobic residues Leu51, Leu79 and Phe111 that were 
exposed to solvent in core-bradavidin because of its truncated C-terminus 
(missing the residues Ala128-Lys138 of wt bradavidin) and thought to affect 
solubility. Again, ligand binding was not significantly different from core-
bradavidin, and solubility was not increased either. Ligand binding and 
characterization of both the CC mutant and the V1 variant were made in 
Docent Hytönen’s lab (University of Tampere).  
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In order to understand the Brad-tag binding mode further, we modeled two 
Brad-tag containing Avds: rhodavidin from Rhodopseudomonas palustris 
(Larimer et al., 2004) and bradavidin A2 from Bradyrhizobium sp. Ai1a-2. 
Based on our modeling results, the Brad-tag binding mode of rhodavidin 
and bradavidin A2 were similar to wt bradavidin. The few amino acid 
differences at the beginning of the Brad-tag region and within the extended 
linker region in rhodavidin and bradavidin A2, in comparison to wt 
bradavidin, are likely not to affect the Brad-tag binding of rhodavidin and 
bradavidin A2, but this has not yet been tested experimentally. 
Btn easily displaces peptide ligands during competitive binding assays. 
However, the presence of a peptide ligand hinders the Btn-binding affinity 
in Avds. The reason for the existence and the exact role of intrinsic peptide 
ligands in Avds have been discussed recently (Avraham et al., 2015; 
Leppiniemi et al., 2012) but the function of the intrinsic peptides is not 
entirely known. One possible reason for the presence of peptide ligands in 
bacterial Avds may be to help regulate Btn intake and release, suggesting a 
Btn-transporter role of Avd in the host organism, similar to BBPs (Hytӧnen 
et al., 2007). Avds may help distribute Btn inside the bacterial cell close to 
the sites where Btn is needed; for example, Btn molecules are cofactors for 
carboxylase enzymes, which are essential for gluconeogenesis and fatty acid 
synthesis (Dakshinamurti et al., 1985) and hence access to readily available 
Btn close to the site where these reactions take place could be necessary. 
Especially, the relatively low affinity Btn-binding bacterial Avds (i.e. not 
streptavidin) could have this biological role.  
The X-ray structure of the core-bradavidin–Btn complex described in 
publication III did not explain how Btn replaces Brad-tag in the ligand-
binding site of the wt bradavidin structure. To address this question, we 
also tried to co-crystallize wt bradavidin with Btn, however, no crystals 
were obtained, possibly due to the highly flexible Brad-tag region still 
present in solution, after being displaced by Btn. By rational mutagenesis 
of the Brad-tag, we sought to increase the binding affinity of the Brad-tag 
for core-bradavidin, but none of the Brad-tag mutants bound core-
bradavidin tighter than the original Brad-tag according to differential 
scanning calorimetry analyses. The affinity of the Brad-tag for bradavidin 
could also be increased by rational mutagenesis of bradavidin itself, but this 
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has not been attempted so far. Similarly, directed evolution approaches 
may lead to a higher-affinity complex between the core-bradavidin–Brad-
tag ligand pair that would be better suited for biotechnological assays, such 
as protocols where Brad-tag could be used as an alternative tag for the 
existing tags for purification of recombinant proteins, or for 
electrochemical biosensing, where the core-bradavidin–Brad-tag ligand 
pair can be used to build multilayered materials in bio(nano)technology. 
6.2 Artificial avidin mutants binding steroid ligands 
The high thermal stability (Tm~80°C), small size (~60 kDa) and low cost of 
production, as well as the architecture of the ligand-binding site, make 
chicken Avd an attractive, alternative receptor scaffold for the wide-range 
of applications where traditional antibodies are currently commonly used.  
Receptor scaffolds can be classified into two broad structural classes: 
domain-sized scaffolds e.g. anticalins; and constrained peptide scaffolds e.g. 
avimers. Even though a number of protein scaffolds are being developed, 
the need for better protein scaffolds is on the rise. According to Vazquez-
Lombardi and coworkers (Vazquez-Lombardi et al., 2015), the next-
generation protein scaffolds face three major hurdles:  
 
i) Most antibodies have a half-life of several weeks inside the body. 
In comparison, scaffolds are mostly passed out of the body after 
reaching the kidney. 
ii) Even though the tissue penetration of scaffolds is much faster 
than antibodies due to their relatively small size, the dose 
toxicity and the manufacturing cost are higher. Currently, 
antibodies can easily access most tissues of the body with lower 
risk.  
iii) Advances in antibody technology due to protein engineering 
have helped produce smaller antibodies and with longer half-
lives, thus reducing the advantage of protein scaffolds to a 
certain degree. 
However, protein scaffolds already hold a lot of benefits (Vazquez-
Lombardi et al., 2015): owing to their smaller size, scaffolds can be locally 
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administered, e.g. in ocular diseases; innovative drug delivery devices can 
exploit their higher solubility; they can have multiple specificity for various 
ligands/drugs, e.g. anticalins and antidins; toxin-conjugated protein 
scaffolds can penetrate tumor tissues easily and upon delivery excreted out 
of the body much faster than antibodies. 
Steroid-binding Avds (sbAvds) were recently developed in our 
collaborators’ laboratory (Prof. Emeritus Markku Kulomaa’s and Docent 
Vesa Hytönen’s research groups, University of Tampere; Riihimäki et al., 
2011a) and these chicken Avd-based receptors were named antidins 
(antibodies + avidins). In this study, 3D structure-based analysis of antidins 
was carried out to help further engineer and develop the steroid-binding 
antidins. 
The first antidins, sbAvd-1 and sbAvd-2 were selected using phage display 
and panning against testosterone (Riihimäki et al., 2011a). For sbAvd-1, 
Riihimäki and co-workers constructed a phage display library (Avd L1,2 
library), in which the residues Asn12-Ser16 of the L1,2 loop of chicken Avd 
were randomly replaced by other amino acids. The sbAvd-1 antidin carried 
the mutations D13R, L14M, G15N, and S16H and had a micromolar 
affinity to testosterone and progesterone but retained nanomolar affinity to 
Btn. To further reduce the Btn-binding affinity of sbAvd-1, the sbAvd-1 
L3,4 library was constructed where the residues of the L3,4 loop were 
allowed to be randomly mutated except for tryptophan, glutamine, 
glutamate, methionine, and lysine; sbAvd-2 was selected from this library 
and carried the mutations T35A, A36T, and T38N in the L3,4 loop region 
in addition to the L1,2 loop region mutations of sbAvd-1 (Riihimäki et al., 
2011a). In comparison to sbAvd-1, sbAvd-2 had increased affinity to 
testosterone (3  M) and progesterone (0.1  M) along with a reduced 
binding affinity to Btn (7  M) in a fluorometric assay. 
In order to understand the binding mode of sbAvd-2, and of sbAvds both 
in general and in atomic detail, sbAvd-2 carrying the point mutation I117Y 
was crystallized in the apo form, and sbAvd-2 (I117Y) was co-crystallized 
with progesterone and testosterone. Crystals were obtained within a few 
weeks for sbAvd-2 (I117Y) without a ligand and after co-crystallization 
with testosterone and progesterone. However, crystals of size large enough 
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for mounting and of high enough quality for detecting initial diffraction 
using a PX Scanner, and for data collection at ESRF, were obtained only for 
the unligated form of sbAvd-2 (I117Y) [PDB:4U46] (I) and for sbAvd-2 
(I117Y) co-crystallized with progesterone [PDB:5LUR] (II); the reason for 
not getting crystals with testosterone maybe related to the low solubility 
and hydrophobic properties of testosterone, which may have affected 
proper complex formation or crystal lattice formation. 
The X-ray structure of the sbAvd-2 (I117Y)–progesterone complex 
[PDB:5LUR] helps us understand the mode of, and pinpoint the important 
residues involved in, progesterone binding. The L3,4 loop in the 
progesterone-bound complex structure [PDB:5LUR] is in an open 
conformation and residues Asn38-Ser41 lacked electron density, similar to 
the sbAvd-2 (I117Y) apo structure [PDB:4U46]. The open conformation of 
the L3,4 loop is not observed in Avd-Btn complex structures but is clearly 
needed to allow bulkier-than-Btn ligands to bind and fit to the otherwise 
too narrow binding pocket; in Btn binding the closed conformation of the 
L3,4 loop seals the hydrophobic moieties of Btn from the solvent and 
enables the perfect fit between the ligand and the “receptor” (extremely 
high affinity) but, in the case of progesterone, the size and shape of the 
ligand restrict the fit (lower affinity). 
The X-ray structure of these two sbAvd structures allowed us to study the 
progesterone-binding mode at the atomic level and assisted in the further 
development of antidins through prediction of future mutations to 
improve the progesterone-binding affinity. For example, after detailed 
analysis of the sbAvd-2 (I117Y)–progesterone complex, we suggested 
mutations to key residues (e.g. A35V, V37L) near the binding site which 
may further contribute to progesterone binding by increasing the H-
bonding network with the 3-keto group of progesterone (Figure 4, 
manuscript II). 
6.2.1 Docking analysis of ligands – Out of the tested antidins in 
publication I and manuscript II (Table 2, publication I; Table 2, manuscript 
II), the antidins sbAvd-7–9 selected from AvLib-4 based on the 
progesterone panning bound progesterone with nanomolar affinity in a 
fluorometry-based assay. Thus, these antidins were selected for docking 
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analysis with progesterone and Btn in order to gain insight on their possible 
ligand-binding modes. Here, the aim was to identify the residues and 
interactions responsible for high-affinity progesterone binding and the 
residues that might lower the Btn-binding affinity. Even though our 
docking analysis could not explain the differences in the progesterone 
binding affinities, our Btn-docking analysis did support the role of His16 
in hindering Btn binding in agreement with our earlier predictions based 
on the crystal structure of sbAvd-2 (I117Y) (I).  
We assumed that all of the antidins derived from AvLib-3 and AvLib-4, e.g. 
sbAvd-1, sbAvd-2, and sbAvd-7–9, could bind progesterone as was seen in 
the progesterone-bound crystal structure of sbAvd-2 (I117Y) [PDB:5LUR]. 
However, progesterone has a “pseudo-symmetrical” structure, having a 
tetracyclic sterane skeleton with a methyl group present at C10 and C13, 
and polar functional groups attached at C3 and C17 (Moss, 1989; Steroids, 
2017). This makes it difficult for docking programs to predict the 
orientation of steroids within the ligand-binding site of the antidins; and 
model structures with inherent errors used for docking do not make this 
task easier. Moreover, the rigidity of the sterane tetracyclic rings restricts 
the flexibility of the progesterone ligand, except at the functional groups, 
increasing the challenge even further. In many of the progesterone docking 
complexes of sbAvd-7–9, the progesterone ligand was ‘A-ring’ first inside 
the binding site, instead of ‘D-ring’ first (X-ray structure), as it was 
energetically favorable according to the docking algorithm (Figure 5a). A 
similar phenomenon was observed in our earlier automated docking 
analysis, in which the docking poses of progesterone were also inverted in 
comparison to the X-ray structure. 
Similar challenges were also observed by Panek and coworkers (Panek et 
al., 2017), who tested the binding mode of progesterone and other steroids 
to human mineralocorticoid receptor and a bacterial monooxygenase 
through computational docking and molecular dynamic studies. In both 
cases, the steroids docked in at least two orientations, A-ring first and D-
ring first, even though the X-ray structure used for their analysis had 
progesterone placed A-ring first.  
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Therefore, without experimental evidence, it is challenging to dock steroids 
in the correct orientation. The consensus among results obtained from 
various docking approaches and scoring functions may help to reduce the 
uncertainty.  
Although antidins sbAvd-7–9 bind progesterone with nanomolar affinity, 
and Btn binds with high affinity, sbAvd-7–9 could be used in Btn-free 
assays, e.g. for steroids.  
6.3 Multipurpose avidins 
The search for novel Avds have come a long way since the 1940s when 
chicken Avd was newly discovered. Not only have novel Avds across 
prokaryotic/eukaryotic species been successfully identified, but various 
forms of engineered Avds have also been developed. With the 
characterization of bradavidin and chicken Avd-based antidins, we now 
have natural and artificial protein scaffolds possessing binding affinities for 
non-Btn ligands, e.g. steroids and the peptide ligand Brad-tag. Upon 
reaching the desired binding affinity, these scaffolds could be used to 
construct a circular mutant, dual chain/single chain form with, e.g. two 
high-affinity sites for one ligand and two other sites, for the second ligand, 
or multifunctional Avds with subunits having lowered or no affinity to Btn 
(Laitinen et al., 1999; Leppiniemi et al., 2011; Morag et al., 1996; Reznik et 
al., 1998; Takakura et al., 2013), or scAvds with ‘dead’ subunits that do not 
bind ligands (Howarth et al., 2006). In the future, these multipurpose Avds 
may have use in various branches of bio(nano)technology. 
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7. Conclusion 
In this thesis, we present: i) crystal structures of a novel sbAvd, sbAvd-2 
(I117Y) in apo [PDB:4U46] and progesterone-bound form [PDB:5LUR], 
and core-bradavidin–Btn complex [PDB:4BBO]; ii) models of Brad-tag 
containing Avds and steroid-binding sbAvd-7–9; and iii) computational 
binding studies on the modeled antidins with progesterone and Btn. 
Through these results, we probed the structural determinants responsible 
for binding Btn and, especially, non-Btn ligands in natural and artificial 
Avds. 
In publication I, we successfully developed a number of antidins capable of 
binding steroids like progesterone and small molecules such as cholic acid 
with micromolar and nanomolar affinity. The crystal structure of apo 
sbAvd-2 (I117Y) reported in publication I proved the robustness of the 
antidin scaffold and helped further design of antidins. In manuscript II, we 
expanded our arsenal further by developing antidins binding specific 
steroids, for example, progesterone. The potency of a few selected antidins 
were tested using a microplate-based assay to detect progesterone in female 
dog serum samples in order to monitor breeding times. Thus, antidins have 
the potential to replace antibodies in diagnostics if higher affinities can be 
achieved. We also reported the crystal structure of the sbAvd-2 (I117Y) in 
complex with progesterone, which gave us critical insight into the 
progesterone binding mode of Arg13, Met14, Asn15 and His16 containing 
sbAvds. This structure also helped us build computational models for the 
high-affinity progesterone binders, sbAvd-7–9, to which we docked 
progesterone and Btn to study key interactions formed during ligand 
binding. A large number of the docked progesterone poses obtained from 
the docking complexes were inverted in comparison to the progesterone 
ligand in the crystal structure of sbAvd-2 (I117Y)–progesterone complex 
[PDB:5LUR]. This study underscored the shortcomings of ligand-docking 
programs when the structure has been modeled or does not reflect the 
binding conformation.  
In publication III, we focused on bradavidin, a bacterial Avd from 
Bradyrhizobium diazoefficiens (Delamuta et al., 2013; Nordlund et al., 
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2005b). Through the determination of the core-bradavidin–Btn complex 
crystal structure, we were able to study the ligand-binding mechanism of 
bradavidin with two ligands, Brad-tag and Btn. We constructed two 
variants of bradavidin: the core-bradavidin CC mutant used for testing the 
importance of the disulphide bridge in ligand binding, and the core-
bradavidin V1 variant used for masking the exposed hydrophobic residues 
in core-bradavidin. Biophysical analyses of these variants did not reveal any 
significant differences in Btn-binding affinity in comparison to core-
bradavidin, but the low yield of the CC mutant protein indicated a possible 
role of the disulphide bridge in protein folding; the role of the disulphide 
bridge for Brad-tag binding could not be excluded either. Models of two 
Brad-tag containing Avds – rhodavidin and Bradavidin A2 – were also built 
to observe their Brad-tag binding mode, which is unlikely to be different 
from wt bradavidin. Overall, the comparison of the wt and core-bradavidin 
structures, and the core-bradavidin variants, helped us to understand how 
Btn and the intrinsic peptide ligand could both bind to an Avd scaffold.  
In the future, through the identification of novel Avds from phylogenetic 
studies including more and more examples from different species, and by 
the construction of additional high-affinity steroid-binding and other non-
Btn ligand-binding antidins, we should be able to develop high-affinity 
multipurpose dc/sc Avds, capable of binding varied ligands simultaneously 
and henceforth be able to propel the Avd-Btn technology even further. 
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